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ABSTRACT
CHARACTERIZING THE ROLE OF EXTRACELLULAR MATRIX IN NONSMALL CELL LUNG CARCINOMA METASTASIS USING A 3D
MICROENVIRONMENT MIMETIC IN-VITRO CULTURE SYSTEM
Douglas J. Owulaku Saforo
July 23, 2019

Lung cancer is the leading cause of cancer related death in the United
States and worldwide. Five-year survival rates for non-small cell lung carcinoma
patients have not improved in decades, and a majority of patients succumb to
metastasis. Identification of therapeutic targets for metastatic disease is essential
for the development of novel therapies. However, current 2-dimensional (2D) in
vitro models are not reflective of the tumor microenvironment (TME) and are
inadequate in identifying therapeutic targets.
We adapted a 3-dimensional (3D) extracellular matrix (ECM) in vitro
model to a hypoxic incubator to approximate physiological hypoxia of the TME in
a microenvironment mimetic culture system. Our overall objective is to determine
how ECM interactions with lung adenocarcinoma cells can promote hallmarks of
cancer metastasis in a physiologically relevant in vitro system. We assessed
three interactions within the TME: the interaction of cancer cells with ECM, the
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interaction of cancer associated stroma with ECM, and the influence of
environment on ECM remodeling.
Using established and primary cell lines to produce cell-derived ECM
(CDM), we found that lung carcinoma cells grown on 3D CDM adopt a
mesenchymal mode of 3D migration and are significantly more invasive
compared to 2D. The invasive phenotype was attenuated by inhibitors
downstream of “outside-in” integrin signaling including focal adhesion kinase and
Src family kinases. 3D CDM and physiological hypoxia enhanced the isolation
and proliferation of primary tumor stroma isolated from cancer resections of early
stage patients. Patient derived cell lines maintained a stem-like phenotype and
expression of tumor promoting factors in an environment dependent manner.
Further, they promoted metastasis in a xenograft model and CDM produced from
patient derived stroma altered invasive characteristics in cancer cells compared
to normal lung fibroblast CDM.
Using our microenvironment mimetic model, we demonstrate that we can
study ECM-to-cell interactions in a way not possible for traditional 2D models.
These interactions play a pivotal role in determining the fate of cancer cells and
modulate metastatic potential. Understanding how remodeling of the TME is
involved in late stage disease will allow development of preventative and curative
therapeutic strategies to halt tumor progression and metastasis.
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CHAPTER I: INTRODUCTION
Lung cancer characteristics and mortality
Of the solid malignancies, lung cancer accounts for the greatest number of
new cancer diagnoses worldwide with an estimated 2.1 million new cases in
2018 (Siegel, Miller, & Jemal, 2019). It is the most commonly diagnosed cancer
in men, and second most commonly diagnosed cancer in women after breast
cancer. Unfortunately, this particularly insidious disease is the leading cause of
cancer related death in men and often the leading cause of death in women each
year, accounting for 1.8 million deaths last year. In the United States, these grim
statistics have shown little improvement in the last decade. Kentucky bears the
highest lung cancer incidence rate and this outcome is correlated with its topranking smoking rate among the population. Lung cancer is a disease of aging
and commonly affects people over the age of 60. Currently the five-year survival
rate of lung cancer is around 16% overall in men and 21% in women according to
the Center for Disease Control and Prevention and the National Cancer Institute,
with moderately more favorable outcomes associated with the location of the
tumor at the time of diagnosis. Data provided by the National Cancer Institute
and the Surveillance, Epidemiology, and End Results program indicate that
patients in which their disease is detected early, while the tumor is confined to
the primary location and has not disseminated to the adjacent lymph nodes have
a five-year survival rate of approximately 57.4% (Duggan, Anderson, Altekruse,
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Penberthy, & Sherman, 2016). Once the cancer has spread to adjacent regional
lymph nodes, this survival rate drops markedly to 30.8%. Tragically, those
diagnosed with late stage and distant metastatic disease have only a 5.2%
chance of survival past five years. It is a grim fact that a majority of new patients
that will be diagnosed with lung cancer, around 80%, will be informed that they
have regional or distant disease. Metastatic disease is the true killer in lung
cancer.
Lung cancer can classically be divided into two types: small cell and nonsmall cell lung cancer. While small cell lung cancer is a particularly aggressive
and devastating disease, with even locally diagnosed tumors rapidly progressing
and a five-year relative survival rate of just 29%, the biology of small cell lung
cancer is markedly different than that of non-small cell and will not be discussed
in this dissertation. Non-small cell lung cancer is also subdivided into several
histological subtypes including adenocarcinoma, a disease arising from the distal
glandular epithelial lining of the bronchi, squamous cell carcinoma, arising from
the more proximal squamous epithelium of the bronchus, and large cell
carcinoma (Cooper, Lam, O'Toole, & Minna, 2013). Notably, the mean doubling
time of lung adenocarcinoma and squamous cell carcinoma is around 160 days
(Arai et al., 1994). This means that from the time of oncogenic transformation
that results in a tumor cell able to continuously proliferate and evade immune
detection to the time of a detectable tumor mass by chest radiograph can be over
a decade. For the vast majority of this time, patients do not experience pain from
the growing mass and do not experience other related symptoms specific to the
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disease. Often the first symptoms experienced by the patient are associated with
metastatic dissemination such as pain associated with tumor invasion into the
chest wall, liver capsule, or bone structure, or a number of other paraneoplastic
syndromes. This delays the critical time to diagnosis for the patient, leading to
poor outcomes, but also allows ample time for mutated cells to adapt and
modulate a local tumor microenvironment that is conducive to support tumor
growth, progression, and metastasis.
The tumor microenvironment of non-small cell lung carcinoma
The tumor microenvironment of non-small cell lung carcinoma is a
complex and heterogenous combination of cellular and non-cellular tumor
promoting elements that exist and coordinate in a dynamic manner to facilitate
the growth of transformed malignant cells. The cellular constituents include the
malignant transformed cells themselves and possibly their purported stem-like
counterparts, vascular endothelial cells, supporting mesenchymal cells such as
cancer associated fibroblasts and mesenchymal stem cells, and immune cells
that have been modulated toward a wound healing or immunosuppressive
phenotype such as macrophages and helper T cells (Quail & Joyce, 2013). The
non-cellular components include the factors and cytokines that these cells
produce such as vascular endothelial growth factor (VEGF), transforming growth
factor beta (TGF-β), hepatocyte growth factor (HGF), and others (Maman & Witz,
2018). Cancer associate fibroblasts and macrophages are primarily responsible
for extracellular matrix deposition and facilitate its remodeling respectively
(Alexander & Cukierman, 2016; Kalluri, 2016). These processes are facilitated by
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enhanced deposition of extracellular matrix proteins like fibronectin, laminin,
collagens, and the matrix metalloproteinases (MMP) responsible for degrading
these structures. This dynamic structural regulation and biochemical modulation
of the tumor tissue is essential in providing a microenvironment that facilitates the
transformation of malignant cells and allow further dissemination and survival in
distal body sites normal differentiated cells are ill-adapted to survive. One such
purported transformation that may mediate this cellular plasticity and has been
extensively studied in the context of metastasis is the epithelial to mesenchymal
transition (EMT) (Soltermann et al., 2008).
Epithelial to mesenchymal transition
EMT is a normal process of developing cells within the embryo in which
cells undergo a transition from an epithelial state characterized by a maintenance
of cell polarity, cell-to-cell junctions, and cuboidal morphology to a more
mesenchymal state in which cells lose polarity, gain a more spindle-like
morphology and an increased migratory capacity, separating from surrounding
tissue (Lamouille, Xu, & Derynck, 2014). Upon reaching the appropriate location
or upon stimulus from the environment, the mesenchymal cells are thought to
undergo the reverse process of mesenchymal to epithelial transition (MET) and
revert to an epithelial phenotype. However, this phenomenon is not restricted to
fetal development, as adult somatic cells are implicated to undergo this process
in a regulated manner in response to organ injury in order to repair damaged
tissue in a variety of tissues (Stone et al., 2016). However, as tumors have been
described as “wounds that never heal” (Dvorak, 1986, 2015), this process is

4

hypothesized to be a critical mediator within cancerous tissue to facilitate
metastasis.
Driven by certain mutations in oncogenes, epithelial cells undergo
uncontrolled replication and begin to influence their local environment to respond
to these wound healing signals, and this response aids in the tumors growth as
the dysplastic cells undergo additional transformation and the tumor loses normal
organization and differentiation (Negrini, Gorgoulis, & Halazonetis, 2010). Under
influence from the microenvironment, these atypical cancerous cells undergo
EMT to a more mesenchymal phenotype and express MMP in order to penetrate
the basement membrane of tissue and facilitate migration through the interstitial
fibers of the ECM to reach nutrients and endothelial lined blood vessels or
lymphatic vessels. In a process termed intravasation, these cancerous cells
penetrate through the endothelium in order to reach the bloodstream. A property
that differentiates epithelial cells from mesenchymal cells is the ability of
mesenchymal cells to survive anchorage independent growth. Normally,
epithelial cells that detach from the ECM undergo a process of anchorage
dependent programmed cell death known as “anoikis” (Paoli, Giannoni, &
Chiarugi, 2013). In circulation, the mesenchymal-like phenotype of transformed
cells provides resistance to this form of apoptosis and potentiates survival during
hematogenous dissemination. Accordingly with Paget’s “seed and soil”
hypothesis, many transformed cancer cells enter the circulation but only an
exceedingly small percentage survive and reach to distant metastatic sites,
where they penetrate the blood vessel by extravasation, and migrate to an area

5

within the pre-metastatic niche with favorable growth conditions (Langley &
Fidler, 2011; Paget, 1889). Once established, these mesenchymal-like cells
undergo MET to transition to a more epithelial state, anchor to tissue at a distant
organ, and begin to respond to local growth factors and proliferate.
The processes of EMT and MET are also regulated intracellularly and
extracellularly. Perhaps the most characteristic protein of the epithelial phenotype
is the cell-cell adherence protein epithelial-cadherin (E-cadherin) (Jeanes,
Gottardi, & Yap, 2008; Onder et al., 2008). E-cadherin is member of the calcium
dependent adhesion molecule family of proteins known as cadherins. Cadherins
are transmembrane proteins that link cells together through extracellular
domains, while their intracellular domains bind to β-catenin and serve as linkages
for several other proteins including α-catenin, p120 catenin, and vinculin to form
linkages with the actin cytoskeleton in a complex known as the adherens
junction. The stability of this complex has been demonstrated to be under the
regulation of kinase activity from receptor tyrosine kinases such as epidermal
growth factor receptor (EGFR) as well as non-receptor tyrosine kinases such as
the Src family. For example, Roura et al demonstrated that Src phosphorylation
of tyrosine 654 of β-catenin reduces the binding affinity for e-cadherin and
phosphorylation at this site results in disruption of the adherens complex (Roura,
Miravet, Piedra, Garcia de Herreros, & Dunach, 1999). Additionally, e-cadherin
expression is tightly regulated and repressed by the Snail family of zinc-finger
transcription factors including Snail and Slug, the basic helix-loop-helix protein
Twist, and others. Importantly, aberrant e-cadherin expression and localization is
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a feature of advanced tumor progression and correlates with increased
invasiveness of tumors, whereas overexpression of e-cadherin can suppress
invasion in some cancer cell types. The loss of e-cadherin and cell-to-cell
contacts is coupled with the expression of neural cadherin (N-cadherin) and other
proteins such as vimentin, alpha-smooth muscle actin, and fibronectin which are
associated with a mesenchymal phenotype. The stabilization of this
mesenchymal state also confers an increased motility to cells to facilitate
migration of single cells from the primary tumor (Aiello et al., 2018).
Cell migration and invasion processes in 2D and 3D environments
Cell migration is a critical component of cancer metastasis. The molecular
aspects of cell migration have been studied extensively in-vitro predominantly
using slow moving fibroblasts or rapidly and uniformly motile keratinocytes.
These experiments have led to a proposed multistep mechanism of migration by
which cells first establish polarity toward an inducing extracellular stimulus
creating frontward protruding adhesions at the leading edge and contracting
adhesions at the rear of the cell in order to propel the cell forward. Next, actin is
assembled at the leading edge of the cell in various cellular protrusions, each
with specialized machinery and distinct actin morphologies. One of these
protrusions, the lamellopodia, is composed of dense, branched actin networks
under the control of the actin nucleator actin-related protein 2/3 (ARP2/3),
Wiskott-Aldrich syndrome protein (WASP), WASP-family verprolin homologous
protein (WAVE), cofilin, and other proteins (Lai et al., 2008; Machesky & Insall,
1998) that exert a protruding force on the inner surface of the cell membrane in
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order to extend the cytoplasm forward. Filopodia, another classification of cellular
protrusion, are composed of parallel aligned actin filaments (F-actin) that extend
toward the cell membrane with their positive, ATP-bound barbed ends to probe
the extracellular environment while the negative, ADP-bound pointed ends are
oriented toward the cell interior (Mattila & Lappalainen, 2008). Adhesive force
and tension mediated by myosin machinery result in rearward retraction of this
actin filament and aid in propelling the cell forward. In the last step of migration,
adhesions at the rear of the cell are disassembled allowing localized detachment
of the cell body and contractile forces by myosin motor proteins including myosin
II to generate force to retract the rear of the cell and propel the cell body forward.
These adhesions are composed of various cell adhesion molecules that
form, mature, and disassemble rapidly and dynamically. Adhesion formation is
thought to begin with the formation of the nascent adhesion. These nascent
adhesions are composed of kindlin-2, α-actinin, vinculin and other proteins that
loosely attach the cells actin cytoskeleton to the extracellular environment via a
heterodimer of transmembrane proteins known as integrin receptors (Sun,
Lambacher, & Fässler, 2014). Integrins bind to several different protein motifs on
extracellular proteins such as collagen (DGEA), fibronectin, laminin, and
vitronectin (RGD), and others (Horton et al., 2016). As the focal complex recruits
additional force sensitive proteins including talin, kindlin-1, and paxillin, more
integrin pairs are recruited to the adhesion in a process known as clustering,
creating further binding sites for accessory adhesion proteins such as focal
adhesion kinase (FAK) and integrin linked kinase (ILK). Force generated by the
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extracellular integrin linkage and dense bundles of F-actin cytoskeleton known as
stress fibers assists in the maturation of nascent adhesions to larger signal
transducing structures known as focal adhesions (Tai, Chen, & Shen, 2015).
Focal adhesions generate signals through focal adhesion kinase and other
kinases in order to modulate a wide variety of cell processes including actin
remodeling, cellular contraction, proliferation, survival, migration, and invasion
(Fig. 1). In some cases, these focal adhesions can mature further to fibrillar
adhesions, which lose their force reactive properties and do not bind to actin
stress fibers. In other cases, focal adhesions are rapidly disassembled in a
process dependent upon FAK (Geiger & Yamada, 2011; Hamadi, 2005). Thus,
FAK plays a central role in the dynamic regulation of focal adhesions within cells.
While the mechanisms of cell migration are fairly well characterized under
in vitro conditions in which cells are grown on a 2-dimensional (2D) substrate,
less is known about the migration of cells in-vivo, where cells maintain
connections through adherens junctions as they migrate in a process termed
collective cell migration and are surrounded on all sides by extracellular
substrates including ECM (3D), and these are active areas of research.
Fibroblasts and cancer cells grown on plates coated with ECM substrates such
as collagen, fibronectin, or vitronectin exhibit markedly different morphological
characteristics than those grown on glass or plastic. On surfaces coated with
fibrillar collagen gels, fibroblasts form adhesions along the fibers of the matrix,
providing them with an elongated spindle shape with parallel arrangements
similar to mesenchymal cells embedded within connective tissue in-vivo such as
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cartilage (P. Friedl & Brocker, 2000). This change in cell structure is
accompanied by a difference in migratory function as fibroblasts and cancer cells
grown on 3D substrates alter their cytoskeleton and matrix adhesions to facilitate
travel through a more complex architecture compared to a flat surface. The first
of these migratory strategies is termed mesenchymal migration in which cells
utilize extended cellular projections classified as pseudopodia to form matrix
adhesions including integrins to anchor to the matrix stabilized with F-actin,
decrease their velocity, and localize matrix degrading enzymes like MMPs to
degrade through migratory barriers. In the second form of 3D migration, termed
amoeboid migration, cells decrease their matrix adhesions, allowing the cell body
to become more rounded, increase contractile activity to produce membrane
blebs, and squeeze through structures in an MMP-independent manner similarly
to the behavior of leukocytes to accomplish high cellular velocities. Cancer cells
in vitro demonstrate both methodologies of migration and can actively alter their
migrations strategy, however whether this behavior is dependent upon a cell
intrinsic regulatory mechanism or is solely a factor of the encountered
extracellular environment are currently active areas of research.
Aside from migration, invasion through the basement membrane into
surrounding structures is a critical parameter for cancer dissemination and
metastasis, as invasive tumors are characteristic of late stage disease.
Frequently this step in the metastatic cascade is modeled through the inclusion
of a basement membrane-like material derived from Englebreth-Holm-Swarm
mouse sarcoma cells and marketed under the trade name Matrigel. Matrigel
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contains a number of constituents found in the basement membrane including
laminins, collagen IV, and entactin, as well as an assortment of growth factors
and cytokines including EGF, transforming growth factor beta (TGF-β), and
platelet-derived growth factor (PDGF), although it is also available in a growth
factor reduced form. Classically, this material is used to coat the upper surface of
a porous membrane where the gel is polymerized to a thin matrix coating.
Cancer cells are placed on top of this membrane and the number of cells that
invade through the matrix and migrate to the opposite side of the membrane are
quantified at endpoint. To accomplish this task, cancer cells adapt to their
environment and produce cellular protrusions termed invadopodia. Invadopodia
are critical structures in cell invasion found in aggressive tumor cells but not
normal cells. Their assembly can be promoted through EGFR signaling, and the
cortical actin binding protein cortactin has been found to be necessary for the
early assembly of an F-actin core within these protrusive structures. Src,
downstream of EGFR, has been shown to be a critical mediator of invadopodia
maturation through tyrosine phosphorylation of cortactin and other proteins. The
mature invadopodia promotes invasion through targeting MMP, particularly MT1MMP to the ECM.
Extracellular matrix and microenvironment characteristics that promote
metastasis
Apart from its protein composition, the ECM possesses multiple properties
that promote transformation and plasticity of a variety of cell types. Alterations of
the ECM stiffness, linearity, and density are correlated with worse features in a
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variety of fibrotic pathologies including idiopathic pulmonary fibrosis, liver
cirrhosis, and chronic kidney disease, as well as cancers including those of the
breast, pancreas, and others (Biagini & Ballardini, 1989; Cox & Erler, 2011;
Herrera, Henke, & Bitterman, 2018; Jena & Janjanam, 2018; H. O. Lee et al.,
2011). Fibroblasts and other mesenchymal cells are thought to be primarily
responsible for the deposition and assembly of the complex array of proteins and
proteoglycans which compose the ECM, however frequently other cells within the
microenvironment including epithelial cells and leukocytes also locally organize
and remodel the ECM, cross-linking proteins like fibronectin with collagen or
degrading matrix through MMP secretion and activation. The assembly and
remodeling of the ECM by diseased or desmoplastic tissue can create structures
that facilitate migration of cells by creating tracks or tunnels, create barriers to
leukocyte infiltration, modulate stiffness, and provide a reservoir of zymogens or
matrikines, ECM components that possess binding motifs which can stimulate
growth factor receptors like EGFR, that can be liberated from the ECM by MMP
mediated proteolysis.
Aside from these structural elements, other components of the tumor
microenvironment play an important role in cancer progression and the regulation
of processes such as EMT. For example, cancer associated fibroblasts or
mesenchymal cells (CAM) produce extracellular matrix proteins, but they have
also been shown to secrete a variety of cytokines and growth factors into the
tumor microenvironment to facilitate different elements of tumor growth or play a
role in mediating resistance to chemotherapeutic drugs. During the reciprocal
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cross talk between cancer cells and their supportive CAM stroma, the CAM cells
secrete epidermal growth factor (EGF), hepatocyte growth factor (HGF), and
insulin-like growth factors (IGF) and others to support tumor growth and
proliferation. CAM have also been demonstrated to promote angiogenesis in
tumors through secretion of VEGF and PDGF. Aside from these growth factors,
in a study by Navab et al., gene ontology analysis of expression profiles from
cancer associated fibroblasts and matched normal fibroblasts from NSCLC
patients revealed that enriched genes were associated with associated with
extracellular proteins and membrane-bound proteins, mostly involved in signal
transduction, cell adhesion, and response to cell stress (Navab et al., 2011).
Many of these proteins were also associated with TGF-β regulation, another
growth factor that is secreted by activated CAM cells. Through these studies and
others, it has recently been shown that CAM cells are major influencers of cancer
progression, and understanding the mechanisms that govern the activation and
aberrant gene expression of these activated cells will be critical to the
development of treatments in the future.
One element of the tumor microenvironment important to the regulation of
gene expression in tumor and stromal compartments is hypoxia. Generally, a
growing tumor requires a vascular supply in order to transport nutrients to and
waste from the rapidly dividing cells. The availability of blood supply has been
shown to be a critical determinant of tumor growth. As the tumor grows, the
center of the tumor becomes cut off from the blood supply resulting in a gradual
oxygen deprivation toward the center of the tumor mass resulting in necrosis. To
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compensate, cells that are undergoing hypoxic and nutrient stress express genes
in order to promote the recruitment, migration, and proliferation of endothelial
cells that undergo angiogenesis. Within the tumor microenvironment there is an
imbalance of pro- and anti-angiogenic factors, and this may contribute to the
aberrant vasculature found in tumors characterized by tortuous, dilated and leaky
vessel walls. Many of these genes are under the control of an oxygen sensitive
regulator called hypoxia inducible factor 1 alpha (HIF1-α). HIF1-α expression is
correlated with worse tumor progression and can activate EMT and invasion in
cancer cells. It can enhance expression of several enzymes involved in posttranslational modification of collagen and can lead to stiffer, aligned ECM fibers
that can drive tumor progression. HIF1-α can also alter the expression of MMP
and urokinase plasminogen activator receptor (uPAR), thus hypoxia also plays a
central role in ECM remodeling (Petrova, Annicchiarico-Petruzzelli, Melino, &
Amelio, 2018).
Extracellular matrix remodeling
ECM remodeling is characterized by a balance of ECM deposition and
degradation by MMP and other proteases. One of the major proteolytic systems
important in various fibrotic pathologies is mediated by plasminogen and its
major regulator plasminogen activator inhibitor-1 (PAI-1). The plasminogenplasmin system modulates migration and tissue remodeling by interactions with
the ECM and by regulating signal transduction (Fig. 2). PAI-1 is a serine protease
inhibitor and is the main regulator of the plasminogen activation system. PAI-1
inhibits both tissue-type plasminogen activator (tPA) and urokinase-type
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plasminogen activator (uPA), decreasing the cleavage of plasminogen to the
active enzyme plasmin. Aside from fibrin, plasmin can directly degrade ECM
components such as laminin, proteoglycan, and type IV collagen (Liotta et al.,
1981), inducing matrikine peptides capable of signal transduction, and also
indirectly degrade ECM via activation of several pro-MMPS to their active form
including MMP2, MMP3, MMP9, MMP12, and MMP13 (Jaiswal, Varshney, &
Yadava, 2018) (Ramos-DeSimone et al., 1999). PAI-1 has important biological
activities that extend beyond its inhibition of ECM degradation. PAI-1 activity and
expression have been shown to mediate a number of tumorigenic processes
through its interaction with uPA and other elements of the ECM. PAI-1 exists in
latent and active forms in plasma. Active PAI-1 is unstable and binds to the ECM
protein vitronectin to prevent spontaneous conversion to the latent form (Seiffert,
Mimuro, Schleef, & Loskutoff, 1990). The binding of PAI-1 to vitronectin prevents
integrins from binding to vitronectin, resulting in inhibition of integrin mediated cell
adhesion and migration depending on the cell type (Whitley, Palmieri, Twerdi, &
Church, 2004). However, PAI-1 has also been shown to enhance cell adhesion
and migration of breast cancer cells (Chazaud et al., 2000; Whitley et al., 2004).
Further evidence for the ability of PAI-1 to contribute to tumor progression was
shown by adding PAI-1 to cells in culture. Exogenous PAI-1 was sufficient to
block spontaneous and induced apoptosis, possibly by upregulating c-Jun/ERK
and BCLxl, while downregulating BAX expression (Balsara & Ploplis, 2008).
Interestingly, inhibitors of PAI-1 block cellular migration and invasion in murine
cancer models, as well as the seeding of lung cancer cells in the lungs of mice,
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preventing lung cancer metastasis through inhibition of host interactions and
independently of tumor PAI-1 levels (Masuda et al., 2013). In the clinical setting,
elevated plasma PAI-1 levels are associated with poor prognosis in cancer
patients (Look et al., 2002; Pavey, Hawson, & Marsh, 2001). Importantly,
increased PAI-1 expression in lung cancer patients correlates with cancer
mortality (Di Bernardo, Matakidou, Eisen, Houlston, & Consortium, 2009; Gemma
et al., 2001; Pappot, Pedersen, Brunner, & Christensen, 2006; Pappot, Skov,
Pyke, & Grondahl-Hansen, 1997). Through these mechanisms and others, PAI-1
has been shown to be involved in cancer development, growth (Jing et al., 2012),
and metastasis through inhibition of apoptosis (Balsara & Ploplis, 2008),
increased tumor cell adhesion to endothelium (Prager, Breuss, Steurer, Mihaly, &
Binder, 2004), proliferation (Y. P. Zhang et al., 2013), and disruption of tumor cell
interaction with the extracellular matrix (Czekay, Aertgeerts, Curriden, &
Loskutoff, 2003). These studies highlight the importance of studying the stromal
and supporting elements of the tumor microenvironment, and particularly ECM
interactions of cancer cells.
In-vitro models of the tumor microenvironment
In order to recapitulate structural elements of the tumor microenvironment,
researchers have utilized in-vitro strategies that include preparation of collagen
gels on plastic or glass slides. Variations in the fibrillar structure of these matrices
can be achieved through changing their preparation parameters including varying
concentration, temperature, and chemically induced crosslinking of fibers.
Fibroblasts and cancer cells grown on these fibrillar gels exhibit distinct
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morphological differences, including extension of long, thin, cellular projections
termed pseudopodia that extend outward from the cell to connect to the matrix.
Alterations of the stiffness of the collagen matrix are capable of altering the
invasive capabilities of cancer cells. MDA-MB 231 breast cancer cells exhibit a
biphasic invasive response that depends on the concentration, stiffness, and
porosity of the hydrogel, where they exhibit greater invasive behavior on soft and
crosslinked matrices and stiff, porous matrices (Lang et al., 2015). While these
constructs are useful in studying cell-matrix interactions, they may be insufficient
in recapitulating some of the ECM alterations associated with the tumor
microenvironment. For example, when collagen gels are combined with Matrigel,
H1299 lung cancer cells alter their morphology and migration characteristics
(Anguiano et al., 2017). In a collagen hydrogel, the cells adopted a mesenchymal
migration phenotype with polarization of the cell body and lamellipodia adhesions
at the front and rear of the cell. In the combined collagen and Matrigel matrix, the
cells shifted to short, blunted lobopodia protrusions to navigate the matrix, and
the maintenance of this mesenchymal phenotype required β1 and β3 integrin
matrix adhesion. In contrast to single or dual ECM component approaches, an
alternative method to produce ECM is directly from cell culture of the main ECM
producing cells in the body, the fibroblast. Cultured at confluence, and supported
with supplements of ascorbic acid to promote collagen deposition and
crosslinking over the course of a week or more, fibroblasts and other
mesenchymal cells produce an ECM that contains protein constituents found in
tissue, and is organized and cross-linked by depositing cells to recapitulate the in
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vivo microenvironment. These culture plates are then denuded of cells using
methods which preserve the structural and biochemical components of the ECM
and are then carefully washed and treated with DNA digesting enzymes to
remove nuclear debris from the glycosylated matrix. Following cell extraction, the
cell derived ECM constructs are used as scaffolds for cells to study cell-matrix
interactions and downstream behaviors. In a landmark study, Cukierman et al.
demonstrated that 3T3 mouse embryonic fibroblasts (MEF) attach to 2D
fibronectin differently than fibroblasts attach to the ECM in vivo, and that these
cell-matrix adhesions could be recapitulated when fibroblasts were grown on a
fibroblast-derived ECM. These matrix adhesions were characterized with triple
localization of α5 integrin, paxillin, and fibronectin (Cukierman, Pankov, Stevens,
& Yamada, 2001). Other components of these matrix adhesions included αactinin, F-actin, talin, tensin, and vinculin, however these components were
shared by focal and fibrillar adhesions.
This work served as a catalyst for investigators to use this system to study
cell-matrix adhesions and ECM dependent cell signaling and behavior in a
variety of contexts, including vasculogenesis (Soucy, Hoh, Heinz, Hoh, & Romer,
2015), stem cell differentiation (X. D. Chen, Dusevich, Feng, Manolagas, & Jilka,
2007), and cancer biology (Scherzer et al., 2015). Soucy et al. used
immunofluorescence microscopy to characterize a lung fibroblast derived ECM to
contain fibronectin, tenascin-C, collagen I, collagen IV, and collagen IV, among
others (Soucy & Romer, 2009). While many of these proteins colocalized,
fibronectin had a more unique distribution. Human umbilical vein endothelial cells
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(HUVEC) grown on these lung fibroblast derived ECM were found to have cell
matrix adhesions containing β1 integrin, phospho-tyrosine 397 FAK, phosphotyrosine 410 p130Cas, vinculin, and talin. Additionally, these matrix adhesions
localized with MT1-MMP, suggesting an association with invadopodia formation.
Remarkably, HUVEC grown on lung fibroblast ECM formed tubular networks
after 24 hours, demonstrating the benefits of physiologically relevant cell culture
systems on tubulogenesis.
Previously in our lab, Scherzer et al extended this lung fibroblast derived
ECM to study the interaction of lung adenocarcinoma cells with the extracellular
matrix (Scherzer et al., 2015). Among the findings of that study were marked
differences in cell morphology of A549 to an elongated appearance, resistance to
serum withdrawal and chemically induced hypoxia, increased migration velocity
and directionality, and a decrease in E-cadherin expression. The characterization
of this model in the context of lung cancer allows us to now ask questions related
to lung cancer cell metastatic processes in a physiologically relevant manner. For
example, what signaling mechanisms are induced by cell-matrix interactions with
a lung fibroblast deposited extracellular matrix? What are the cellular
components of these interactions and what ligands do they interact with
extracellularly? What characteristics of cell migration are promoted by
extracellular matrix interactions in the tumor microenvironment and are there
specific signaling mechanisms we could target to inhibit 3D migration? What role
does extracellular matrix remodeling play in the context of NSCLC? Would an invitro physiological microenvironment promote alterations in extracellular matrix
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deposition, and would these altered matrices differentially affect cancer cells or
cancer activated fibroblasts? Does a microenvironment that contains the
extracellular matrix and physiological hypoxia preserve characteristics of lung
tumors found in-vivo? Are the cancer associated stromal elements able to
influence cancer progression through extracellular matrix deposition?
To begin to answer these questions, we formed the hypothesis that a
microenvironment mimetic in-vitro culture system consisting of a lung cell-derived
extracellular matrix and a physiological oxygen environment would preserve and
promote in-vivo tumor characteristics and modulate migration and invasion of
lung adenocarcinoma cells through cell-matrix interactions.
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Overall goal
Determine how ECM interactions with lung adenocarcinoma cells can
promote hallmarks of cancer metastasis in a physiologically relevant in vitro
model.
Overall hypothesis
A microenvironment mimetic in-vitro culture system consisting of a lung
cell-derived extracellular matrix and a physiological oxygen environment would
preserve and promote in-vivo tumor characteristics and modulate migration and
invasion of lung adenocarcinoma cells through cell-matrix interactions.
SPECIFIC AIMS
1. Investigate the mechanism and modality of 3D migration of lung
adenocarcinoma cells on extracellular matrix.
2. Determine the effect of physiological hypoxia and extracellular
matrix on tumor stroma.
3. Determine the effect of extracellular matrix remodeling on lung
cancer metastasis.
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Figure 1. Cell-matrix interactions in cancer cells promote cellular processes involved in
metastasis.
Interactions with extracellular matrix through integrins activate multiple signaling cascades
independently and through crosstalk with growth factor receptors to affect survival, cell
adhesion, cytoskeletal remodeling, proliferation, migration, and adhesion. Matrix
metalloproteinases released from the cell mediate pericellular remodeling of the ECM by
degrading ECM proteins and activate latent growth factors within the microenvironment. These
factors and the matrix peptides further potentiate cell surface receptor signaling. This figure
was modified and adapted from (Lu, Weaver, & Werb, 2012).

(Lu, Weaver, & Werb, 2012)
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Figure 2. Plasminogen activator inhibitor 1 (PAI-1) regulates pericellular proteolysis and
cell migration.
PAI-1 regulates ECM degradation and fibrinolysis directly by inhibiting the catalytic activation
of plasminogen, which is localized to the cell surface by Annexin A2 and S100A10 or embedded
within fibrin clots, to the active enzyme plasmin by either tissue-type plasminogen activator
(tPA) or urokinase-type plasminogen activator (uPA) and its receptor (uPAR). Plasmin
degrades extracellular matrix substrates and activates pro-forms of matrix metalloproteinases
(Pro-MMP) to their active state (MMP). The uPA/uPAR complex also associates with integrins
to induce intracellular signaling through Jak/STAT, FAK, PI3K, and other pathways. Vitronectin,
an ECM protein, has binding sites for PAI-1 and uPAR, however PAI-1 binds with higher affinity
and can prevent association with the receptor. PAI-1/uPAR complexes are internalized within
the cell, where the PAI-1 is targeted for lysosomal degradation and uPAR is recycled to the cell
surface to facilitate attachment and migration of the cell. PAI-1 also interacts with intracellular
substrates such as caspase 3 to inhibit apoptosis, and may be involved with other intracellular
activity associated with migration.
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CHAPTER II: MATERIALS AND METHODS
Human tissue samples
Primary human lung cancer resections (six) were acquired and de-identified from
patients undergoing resection of pulmonary tumors without preoperative
chemotherapy or radiotherapy at the James Graham Brown Cancer Center at the
University of Louisville. Patients with lung adenocarcinoma and squamous cell
carcinoma were staged according to the tumor-node-metastasis system
established by the American Joint Committee on Cancer. This study was
approved by the IRB committee of the University of Louisville (#130188) and
informed consent was obtained from all patients. All experiments were performed
in accordance with relevant guidelines and regulations.
Hypoxic cell culture
Hypoxic cell culture conditions (5% O2, 5% CO2, 90% N2, 37ºC) were achieved
with a modified water jacketed cell culture incubator equipped with a ProOx P110
oxygen controller (BioSpherix, Parish, NY). The sensor was calibrated and
programmed to maintain a setpoint of 5% O2 via infusion of Ultra High Purity
Nitrogen gas unless otherwise stated.
Patient sample processing
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Tumor resections were transported on ice, transferred to a sterile 100 mm cell
culture plate in ice-cold PBS, imaged and placed in a sterile laminar flow hood.
The tissue was diced to approximately 1mm3 pieces. The diced tissue was
transferred to a vial containing collagenase/dispase (Sigma, St. Louis, MO)
dissolved (1mg/mL) in serum free Dulbecco’s modified Eagle’s medium-high
glucose (DMEM) for enzymatic digestion. The vial was warmed to 37º C and
incubated with rocking for at least 1 h 15 m. The tissue suspension was agitated
with vigorous pipetting to confirm tissue dissociation and either returned to 37º C
if incomplete or inactivated. Cell suspensions passed through a 70 µM cell
strainer. A syringe plunger was used to force remaining tissue through the
strainer and the strainer washed with ice cold PBS. The tissue suspension was
cooled to 4ºC and then placed in a centrifuge for 3 minutes at 400 cfg and 4ºC.
The supernatant was aspirated and the cell pellet suspended in growth medium
(DMEM 2% FBS, Pen/Strep, Cipro). Cell and viability counts were obtained with
a TC20 automated cell counter (Bio-rad), and cells were placed onto a plate
coated with human cell derived extracellular matrix and maintained in a climatecontrolled incubator at 37ºC, 5% CO2, and 5% O2 (Fig. 14A). Cells were
monitored for attachment and healthy morphology at 24 hours post culture and
the media was changed 4 or 7 days post culture depending on cell attachment.
Cell culture
Human normal fetal lung fibroblast cell lines WI38 and IMR90 were purchased
from American Type Culture Collection (ATCC) and maintained in Minimum
Essential Medium Alpha modification (MEM-α) supplemented with L-Gln, ribo25

and deoxyribonucleosides (Fisher),10% fetal bovine serum (Invitrogen) and 1%
antibiotic/antimycotic (Sigma). Human bone marrow mesenchymal stem cells
(hMSC) were purchased from Lonza and cultured as the fetal lung fibroblast cell
lines. Human embryonic stem cell line H1(WiCell, Madison, WI) was cultured on
human embryonic stem cell‐qualified Matrigel‐coated plates (BD Biosciences,
San Jose, CA) in mTeSR1 media (STEMCELL Technologies, Vancouver,
Canada), with media changed daily. All assays involving comparisons between
tumor derived stromal cell lines (927, 955, 956, 959, 960, and 1072) and
mesenchymal cell lines (WI38, IMR90, and hMSC) were performed with early
passage cells (p < 8) in the same culturing medium, MEMα, described
previously. A549, H2009, and H2030 human adenocarcinoma cells were
purchased from ATCC and were cultured in RPMI medium supplemented with
10% FBS, and 1% antibiotic/antimycotic. A549 NucLight Red human
adenocarcinoma cells (Essen Bioscience) were cultured similarly, and media was
supplemented with 1 µg/mL puromycin. All cell lines were maintained at 37ºC
and 5% CO2, unless otherwise stated.
Extracellular Matrix Preparation
Extracellular matrix preparation was performed as previously described(Scherzer
et al., 2015). Briefly, IMR90 or WI38 fetal lung fibroblasts, or patient derived
mesenchymal cells, were plated at confluence in matrix growth medium (MEM-α,
10% FBS, 1% antibiotic). On the second, fourth, and sixth days, medium was
supplemented with 50 µg/mL L-Ascorbic acid (Sigma) to promote matrix
deposition. On the eighth day, wells were washed with phosphate buffered saline
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(PBS) and cells were lysed with a detergent (20mM NH4OH, 0.5% Triton-X-100)
for 1-3 minute incubation at 37º C until complete cell lysis was observed.
Resulting cell derived matrices were gently washed three times with PBS, and
then incubated with Dnase1 (10 U/mL) for 30 minutes to remove residual DNA.
The matrices were then washed twice in PBS, and either used immediately or
stored at 4ºC in PBS supplemented with 1% antibiotic for up to 4 months.
Microscopy and immunocytochemistry
Phase microscopy images were obtained using a Zeiss AX10 inverted
microscope. A549, H1, and patient derived cells were fixed with 2% PFA/PBS
(10 minutes, 24ºC; Electron Microscopy Sciences, Hatfield, PA), permeabilized
when needed with 0.05% Triton X-100/PBS (5 minutes, 24ºC; Sigma Aldrich, St.
Louis, MO), and blocked with 5% normal goat serum/PBS (Sigma-Aldrich, St.
Louis, MO). Cells were probed with mouse monoclonal antibodies recognizing
SSEA-4 (1:200, ThermoFisher, Walton, MA) and CD90 (PE) (1:200, BD
Biosciences, San Diego, CA) overnight at 4ºC. Cells were washed with PBS and
incubated with goat anti-mouse 488 (1:1000, ThermoFisher, Walton, MA). DAPI
nuclear stain (1:2000; ThermoFisher, Walton, MA) was added (5 minutes, 24ºC),
washed, mounted, and imaged using Olympus IX81 fluorescence microscope
(Center Valley, PA). Live cell time-lapse phase and fluorescence microscopy was
performed using a Cytation 5 Cell Imaging Multi-mode reader (BioTek).
Immunofluorescent images of co-culture experiments with red nuclear A549 were
acquired with a Nikon Eclipse Ti microscope with a 4X objective using NISElements AR acquisition software (Nikon Instruments, Inc., Melville, NY, USA).
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Nuclear counts from equal image thresholds were quantified automatically using
the NIS-Elements AR software.
Cell Proliferation, CFU-F, and Co-culture
Doubling time experiments were performed by plating approximately 4x10 4 cells
in technical duplicates. Mean cell counts were collected at 24 and 96 hours while
cells were in log phase growth counting at least 100 cells in a hemocytometer.
Doubling time was calculated using the formula DT=T ln2/ln(Xe/Xb), where T is
the incubation time, Xb is the cell number at 24 hours, and Xe is the cell number
at 96 hours. CFU-F assay was performed by seeding 50 cells in a 35-mm well.
Media was refreshed on days 7 and 10. Colonies were fixed in methanol and
acetic acid (7:1) on days 14-18 and were stained with crystal violet. Greater than
32 cells were considered colonies. For co-culture studies, stromal cells that had
grown in 3DH (Fig 14A.) were seeded at confluence density on 35mm glass
bottom tissue culture dishes (MatTek) to produce monolayers. After 4 days
growth, 1.5x104 Red A549 cells were seeded onto stromal monolayers and
maintained in RPMI (10% FBS, 1% antibiotic/antimycotic) and monitored daily.
Migration and Invasion
Lung cancer cells were plated at confluence and serum starved overnight
following attachment. A micropipette tip was used to create a scratch in the cell
monolayer and pictures were captured at the indicated time points. 3D invasion
assays were plated using a WI38 derived matrix that had not been supplemented
with ascorbic acid during the growth. Ascorbic acid supplementation or use of
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IMR90 fibroblast matrices results in a matrix that was too thick to reliably scratch.
Invasion assays utilized a layer of Matrigel containing either vehicle or drugs after
the scratch had been made. Images were captured at the indicated timepoints
and results were quantified using the area measurement of imageJ, comparing
the wound closure at the time of the image to the initial wound. Averages of at
least three images were captured for each time point and at least two replicates
were used for each individual experiment.
Spheroid Preparation
Lung cancer cells were culture under normal conditions on a Corning ultralow
attachment 96 well plate (Sigma) at 1x104 cells per well for a period of 6 days to
allow small, rounded spheroids. Spheroids were observed under microscopy and
transferred to matrix plates with a micropipette for further migration studies.
Generation of Human PAI-1 by LentiCRISPRv2
SERPINE1 (PAI-1) -/- cell lines were generated using CRISPR-Cas9 mediated
genome editing as previously described (Shalem et al., 2014). Briefly, we used
selected two guide RNA sequences that targeted the first and second exons of
the SERPINE1 gene. Complimentary oligonucleotides containing the shRNA
sequences (Guide 2: 5’-CACCGAACCACGTTGCGGTCCTTGG-3’; guide 3: 5’CACCGCTGGACGAAGATCGCGTCTG-3’) were digested by BsmBI and cloned
into the lentiCRISPR v2 plasmid (Addgene #52961). Lentivirus was generated
using 293T cells transfected with 6 µg lentiCRISPR v2 or pLX304 containing
SERPINE1 cDNA (DNASU HsCD00440510) plasmids, 3 µg psPAX2, and 1.5 µg
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pMD2.G in optiMEM with a 3:1 ratio of polyethylenimine (PEI) to total DNA.
Lentivirus was collected 48 hours after transfection, twice daily over a two-day
period, and filtered in a 0.22 µm filter. A549, H2030, H2009, and IMR90 cells
were infected twice with lentivirus over a 48 hour period and then selected with
puromycin or blasticidin (for pLX304; 2-50 µg/mL) containing media (0.5-1.5
µg/mL). Single clones were generated by plating low densities of puromycin
resistant cells and isolating single colonies with cloning cylinders after 10-14
days of colony growth. Cell lines were maintained in 0.5 µg/mL puromycin
containing media after selection.
Western Blot
Cells and tissue samples were harvested in CHAPS lysis buffer (1% CHAPS
detergent, 150mM NaCl, 50mM Tris pH7, 5mM EDTA) supplemented with
cOmplete protease inhibitor and PhosSTOP phosphatase inhibitor cocktail
tablets (Sigma-Aldrich, St. Louis, MO). Tissue samples were homogenized in a
mini-bead beater. Protein was quantified by using Pierce’s BCA Protein Assay
Reagent Kit (ThermoFisher, Walton, MA) as per the manufacturer’s instructions.
Total protein (20µg) was heated at 95ºC for 5 minutes and separated by 4-12%
SDS-polyacrylamide gel. Blots were transferred to PVDF membranes for 120
minutes at a constant voltage of 100 V in 4ºC. Membranes were blocked in 5%
milk (w/v) in Tris-buffered saline Tween-20 (TBS-T) at 24ºC for 1 hour. The
membranes were incubated with primary antibody in 5% milk TBS-T overnight at
4ºC. A list of antibodies used for analysis is presented in the supplementary
material.
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Antibody

Host

Catalog

Distributor

HIF-1α (D2U3T)

Rabbit

#14179

Cell Signaling Technologies

p21 Waf1/Cip1 (12D1)

Rabbit

#2947

Cell Signaling Technologies

α-Smooth Muscle Actin

Rabbit

#14968

Cell Signaling Technologies

Src

Rabbit

#2108

Cell Signaling Technologies

P-Src Family (Tyr416)

Rabbit

#2101

Cell Signaling Technologies

P-Paxillin (Tyr118)

Rabbit

#2541

Cell Signaling Technologies

Vimentin (D21H3)

Rabbit

#5741

Cell Signaling Technologies

N-Cadherin

Rabbit

#4061

Cell Signaling Technologies

Slug (C19G7)

Rabbit

#9585

Cell Signaling Technologies

Snail (C15D3)

Rabbit

#3879

Cell Signaling Technologies

EGF Receptor (D38B1)

Rabbit

#4267

Cell Signaling Technologies

P-EGFR(Tyr1068)

Rabbit

#3777

Cell Signaling Technologies

Akt (pan) (C67E7)

Rabbit

#4691

Cell Signaling Technologies

P-Akt (Ser473) (D9E)

Rabbit

#4060

Cell Signaling Technologies

p38 MAPK (D13E1)

Rabbit

#8690

Cell Signaling Technologies

Rabbit

#4511

Cell Signaling Technologies

PAI-1

Mouse

#612024

BD Transduction Labs

Zeb1

Rabbit

#05987

Novus biologicals

E-Cadherin (24E10)

Rabbit

#3195

Cell Signaling Technologies

TGF-β

Rabbit

#3711

Cell Signaling Technologies

LC3B (D11)

Rabbit

#3868

Cell Signaling Technologies

Basic Cytokeratin (AE3)

Mouse

#57004

Santa Cruz

p27 Kip1

Mouse

#610242

BD Biosciences

P-p38 MAPK
(Thr180/Tyr182) (D3F9)
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Antibody

Host

Catalog

Distributor

p44/42 MAPK (Erk1/2)

Rabbit

#4695

Cell Signaling Technologies

Phospho-p44/42 MAPK
(Erk1/2) (Thr202/Tyr204)

Rabbit

#4370

Cell Signaling Technologies

Annexin II (C-10)

Mouse

#28385

Santa Cruz

p-Annexin II (85.Tyr 24)

Mouse

#135753

Santa Cruz

PAI-2

Mouse

#166539

Santa Cruz

Plasminogen

Mouse

#376324

Santa Cruz

Integrin αV

Rabbit

#4711

Cell Signaling Technologies

Integrin β3

Rabbit

#4702

Cell Signaling Technologies

P-Stat3 (Tyr705)

Rabbit

#9131

Cell Signaling Technologies

FAK (D2R2E)

Rabbit

#13009

Cell Signaling Technologies

P-FAK (Tyr397) (D20B1)

Rabbit

#8556

Cell Signaling Technologies

P-FAK (Tyr576/577)

Rabbit

#3281

Cell Signaling Technologies

P-FAK (Tyr925)

Rabbit

#3284

Cell Signaling Technologies

RhoA (67B9)

Rabbit

#2117

Cell Signaling Technologies

ILK1 (4G9)

Rabbit

#3856

Cell Signaling Technologies

GAPDH (D16H11)

Rabbit

#5174

Cell Signaling Technologies

β-Actin

Mouse

#A2228

Sigma

Rabbit IgG HRP

Goat

#7074

Cell Signaling Technologies

Mouse IgG HRP

Horse

#7076

Cell Signaling Technologies

Table 1. Antibodies
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Flow Cytometry
Cultures of A549, hMSC, and patient sample cell lines were collected with trypsin
and washed with PBS. Cells were blocked for 15 min at 4ºC with Fc Block
(#553142, BD Biosciences, Miami, FL, USA). The samples were then stained
with a mix of fluorophore-conjugated anti-human monoclonal antibodies: FITC
CD90 (Thy1), PE CD105, and PerCP/Cy5.5 CD73 (Ecto-5'-nucleotidase) from
BioLegend (San Diego, CA) for 1 h at 4ºC. Stained cells were then examined on
a Becton Dickinson FACScan with FlowJo analysis software.
RT-qPCR
Total RNA from cell culture samples was isolated with E.Z.N.A Total RNA Kit
(Omega), according to the manufacturer’s instructions. Total RNA (350 ng) was
then DNase digested with TURBO DNA-free kit (Invitrogen) per the
manufacturer’s instructions. DNase digested RNA was then reverse transcribed
using High Capacity cDNA Reverse Transcription Kit (ThermoFisher, Walton,
MA). Gene-specific cDNA was quantified with real-time RT-PCR using selfdesigned SYBR assays. Primers for qPCR were manually designed with Primer
Express 3.0 software (Applied Biosystems, Foster City, CA) per the
manufacturer’s instructions for SYBR green dye assays. RT-qPCR was
performed with iTaq Universal Sybr Green Supermix (Bio-Rad). Expression
levels were analyzed using ΔΔCT method and were normalized to β2microglobulin (B2M) mRNA levels. PCR reactions were analyzed on a BioRad
CFX96. Primer sequences are presented in the table below.
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Gene

Forward

Reverse

ZFP42 (REX-1)

TTTGAGTCCTTGGAATACCTAAAGAAA

AATTCTCTCCAACTATCTTTTGTGGAA

TNC (Tenascin C

GAGAACAAGAAGAGCATTCCTGTCA

GGACTTGAATTTCAGGCCTTCA

POSTN (Periostin)

TGGTTATATGAGAATGGAAGGAATGA

GTCAGAATAGCGCTGCGTTGT

NANOG

GAACCTCAGCTACAAACAGGTGAA

TTTCTGCCACCTCTTAGATTTCATT

POU5F1 (Oct4)

CCAAGCTCCTGAAGCAGAAGA

TTGGCTGAATACCTTCCCAAA

SOX2

GCACAACTCGGAGATCAGCA

TCTCCGTCTCCGACAAAAGTTT

CPSG4 (NG2)

CACTGTCCTGCCTGTCAATGA

CCGTCCGTGCTCCTCAGA

VEGFA

CTTGCTGCTCTACCTCCACCAT

GACATCCATGAACTTCACCACTTC

SERPINE1 (PAI-1)

TGAAGATCGAGGTGAACGAGAGT

GCTGAGACTATGACAGCTGTGGAT

B2M

TGACTTTGTCACAGCCCAAGATA

AATGCGGCATCTTCAAACCT

Table 2. RT-qPCR primers

Tumor Xenograft
NRG (NOD/RAG1/2(-/-) IL2Rγ(-/-), #007799) mice were purchased from the
Jackson Laboratory and animal procedures were approved by the institutional
animal care and use committee under IACUC #18214 and all experiments were
performed in accordance with relevant guidelines and regulations. 2.5x106
IMR90, hMSC, 955, and 959 stromal cells were subcutaneously injected alone
(N=3) or co-injected with 5x105 Red A549 (N=8) bilaterally into the flanks of NRG
mice. Mice were euthanized after 30 days and tumors and lungs were resected
from mice. Tissues were fixed in 10% buffered formalin phosphate and paraffin
embedded. Tissue sections were stained with H&E.
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Statistics
Student’s t-tests were used for comparisons between two groups. A one-way
ANOVA with Tukey’s test for multiple comparison were used to determine
statistical significance for multiple groups, unless otherwise stated. Statistical
significance was considered for P-value < 0.05.
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CHAPTER III: INTEGRIN SIGNALING THROUGH CELL MATRIX
ADHESIONS PROMOTE MESENCHYMAL MIGRATION AND
COLLECTIVE INVASION OF LUNG CARCINOMA CELLS ON CELLDERIVED ECM
INTRODUCTION
The extracellular matrix (ECM) is a highly dynamic component of the
tumor microenvironment that dictates the structure and organization of cellular
and tissue elements through providing structural scaffolding and access to
bioactive molecules that mediate tissue growth and differentiation (Burgstaller et
al., 2017; Frantz, Stewart, & Weaver, 2010). The ECM and associated structures,
termed the matrisome, of the lung are composed of a diverse array of proteins
and glycoproteins, such as collagen, elastin, fibronectin, vitronectin, laminin,
osteopontin and others, as well as proteoglycans including perlecan and the
hyalectins decorin, versican, and lumican (Yue, 2014). These protein
components provide much of the tensile and elastic strength of the pulmonary
architecture, while hydrophilic proteoglycans bind to growth factors within the
microenvironment including transforming growth factor beta 1 (Kolb, Margetts,
Sime, & Gauldie, 2001). Both components serve as mediators of cell matrix
interactions. Although the ECM is thought to be mainly deposited by stromal
elements of the tumor microenvironment including cancer activated fibroblasts
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(CAF) or mesenchymal (CAM) cells, cancer cells are also able to interact with
and modify the ECM (B. Lee, Konen, Wilkinson, Marcus, & Jiang, 2017;
Malandrino, Mak, Kamm, & Moeendarbary, 2018).
Cells interact with the various components of the ECM through a variety of
cell surface adhesion molecules including integrins and other glycoprotein
families of selectins, syndecans, the hyaluronic acid receptor CD44, as well as
the integrin associated molecule CD47. Integrins are transmembrane proteins
thought to be the major receptors involved in linking the actin cytoskeleton of the
cell to the extracellular matrix. These low affinity receptors exist as noncovalently
linked heterodimers of subunits α or β of which 18 α subunits and 8 β subunits
combine to form 24 integrins. Each of these integrins contains an N-terminal
globular head region that determines its extracellular ligand specificity, a
transmembrane region, and a short C-terminal cytoplasmic tail which mediates
interactions with intracellular cytoskeletal scaffolding proteins (C. Smith, 2008).
These integrins can be grouped according to their ligand specificity with some
dimers acting as receptors for laminin, collagen, or the Arginylglycylaspartic acid
motif (RGD) found in many ECM proteins including fibronectin, vitronectin, and
osteopontin. Upon binding to their extracellular substrates, several scaffolding
proteins assemble along the integrin cytoplasmic tail including vinculin, paxillin,
the mechanosensing protein talin, the signaling protein focal adhesion kinase
(FAK), and dozens of others (Horton et al., 2016). These integrin mediated cellmatrix structures are dynamic and rapidly assembled to form nascent adhesions
which mature to focal adhesions and fibrillar adhesions. During this process of
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assembly and disassembly, FAK is a major mediator of kinase activity that
regulates many signaling pathways that in turn affect multiple aspects of cell
behavior including survival, proliferation, migration, and invasion (Appeddu,
1996; Schaller, 2010). Importantly, activation of FAK results promotes the
association and stable activation of Src family kinases to promote cell motility,
proteolytic activity, and invasion, and this function is activated in the tumor
microenvironment (Mitra, Lim, Chi, & Schlaepfer, 2006). Importantly, these cell
behaviors are associated with metastasis and epithelial to mesenchymal
transition (EMT) in cancer.
Recently, research interests focusing on cell-matrix interactions have
utilized an in-vitro model that recapitulates the diverse physiology of the ECM
found in different tissues by using three-dimensional (3D) fibroblast cell-derived
ECM (CDM) for tissue culture (Cukierman et al., 2001; Yamada & Cukierman,
2007). Fibroblasts and other cells grown on these 3D CDM exhibit different
properties compared to traditional culture on plastic or 2D ECM protein coated
surfaces, but closely resemble structures and behaviors found in-vivo (Soucy et
al., 2015). Interestingly, a common feature of the cell-matrix adhesions on 3D
CDM is that they contain integrin, FAK, and paxillin, which colocalized to the
ECM protein fibronectin (Cukierman, Pankov, & Yamada, 2002; Soucy & Romer,
2009). Our lab, and others, have shown that cancer cells also alter their
phenotype when grown in 3D collagen matrices (P. Friedl & Alexander, 2011) or
on 3D CDM (Scherzer et al., 2015). In particular, the characteristics of single cell
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migration are vastly altered in 3D and in-vivo environments compared to 2D invitro culture (Fraley et al., 2010; Scherzer et al., 2015).
However, the mechanisms of altered cancer cell migration on these 3D
CDM environments are not completely understood in lung cancer, and many
questions remain. Is collective migration, the behavior of multicellular complexes
maintaining cell to cell contact and migrating as a unit, altered on 3D CDM? What
role does cell-matrix adhesion signaling play in mediating migration and invasion
on 3D CDM and are these pathways similar to 2D signaling? Does culture in a
physiological in-vitro microenvironment alter the invasiveness and EMT
characteristics of lung cancer, and what role does cell-matrix adhesion signaling
play in regulating these phenotypes? To answer these questions, we utilized a
microenvironmental culture system that would recapitulate some elements of the
tumor microenvironment including a lung fibroblast 3D CDM as well as
physiological hypoxia. We hypothesized that within this system, 3D cell-matrix
adhesions to the ECM mediate migration, invasion, and EMT of lung cancer cells
through signaling downstream of integrin binding to fibronectin within the tumor
microenvironment.
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RESULTS
Collective migration patterns of lung cancer cells on cell-derived matrix are
distinct from 2D and dependent on focal adhesion signaling.
Previously in our lab, Scherzer et al. reported that single cell migration
velocity and directionality of lung carcinoma and epithelial cells are increased
when interacting with a lung fibroblast derived ECM (Scherzer et al., 2015).
However, a characteristic of invasive solid carcinomas in vivo is that they
maintain cell-cell adhesions and migrate collectively to invade tissue (P. Friedl,
Locker, Sahai, & Segall, 2012). To understand the biology of collective cell
migration of lung cancer cells, we attempted a variety of models utilizing the cellderived matrix (CDM).
First, we used ultralow attachment plates in order to prepare spheroids of the
lung adenocarcinoma cell line H2030. H2030 originally was derived from a lymph
node of a patient with metastatic lung cancer and this cell line is highly motile.
We transferred these spheroids to either a collagen coated tissue culture plastic
plate (2D), or to a plate coated with CDM from WI38 fetal lung fibroblasts. These
plates were then monitored under time lapse microscopy (Fig. 3) for a 48 hour
period. Videos obtained from these experiments highlight the dynamic nature
with which cells interact with their substrates. Interestingly, we observed that the
cells migrating from the spheroid on the 2D surface appeared to spread more
rapidly than those on the 3D CDM (Fig. 3A) and covered a greater overall area.
As these results are different than we observed from single cell migration studies,
this highlights the importance of studying the cell-cell adhesion forces that can
40

promote migration in a collective manner. We also observed that while cells
migrating from the spheroid on 2D travelled relatively linearly from their point of
origin away from the spheroid, upon interacting with the matrix some cells
appeared to change directing while attached cells followed closely behind. This
polarity was much more obvious on the CDM environment, suggesting a
microenvironmental control of “leader” cells and “follower” cells characteristic of
collective cell migration (Peter Friedl & Gilmour, 2009). Additionally, at later
timepoints we observed dozens of cells streaming and breaking away from the
migrating mass on 3D but not on 2D, suggesting the ECM also plays a role in
dictating the transition from collective to single cell migration.
Further analysis of the tracked individual cells showed that cells interacted
with the matrix and oriented their direction to a specific direction on the ECM,
revealing an anisotropic velocity (Fig. 3B). Higher magnification of the early
timepoints of the videos showed that while cells migrating on 2D possessed
broad, flat lamellopodia projections with rapidly assembling and disassembling
adhesions at the leading edge of the cell, cells migrating on 3D extended longer,
thinner, and more durable protrusions to sense the matrix before migration
occurred (Fig. 3C). These structures resemble the extended cellular projections,
tipped with lamellopodia, employed by fibroblasts to navigate a 3D environment
(Petrie & Yamada, 2012). These structures are known to contain integrins in their
focal contacts, so we asked the question of whether inhibition of integrin
signaling would inhibit migration on 3D CDM.
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During “outside-in” integrin signaling, integrin α and β heterodimers join
and attach to an extracellular ligand. This initiates a focal contact between the
extracellular matrix and the cell which begins to associate intracellular machinery
to strengthen the complex. Major components of this complex are talin, which
binds to the cytoplasmic tail of the β integrin subunit as well as actin, and focal
adhesion kinase (FAK), a major focal adhesion scaffolding protein that has
intrinsic kinase activity and auto-phosphorylates itself upon formation of a focal
contact. Phosphorylation of FAK at Tyr 397 induces a conformational shift that
allows interaction with the SH2 domains of Src family kinases and
phosphatidylinositol 3-kinase (PI3K). Further phosphorylation of FAK by Src at
Tyr 925 promotes association the adaptor protein Grb2 (Appeddu, 1996).
Ultimately, FAK interacts with dozens of proteins involved in signal activation and
transduction including paxillin, Arp2/3, and p190RhoGEF (Schaller, 2010). FAK
overexpression is correlated with worse prognosis in breast (Golubovskaya et al.,
2009), and head and neck squamous cell carcinoma (Canel, 2006; Miyazaki et
al., 2003), and has been found to be overexpressed in many other cancers
(Yoon, Dehart, Murphy, & Lim, 2015). Given the relevance of integrin, FAK, and
Src signaling in cancer and cell matrix adhesions, we used the pharmacological
inhibitors of Src family kinases PP2, and saracatinib, FAK inhibitor Pf-573358
(FAKi), and soluble RGD and RGDS peptides to inhibit integrin on cells grown in
2D and 3D CDM.
After 24 hour exposure to A549 lung adenocarcinoma cells, we found that
treatment with the Src inhibitors PP2 and saracatinib yielded similar results in
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inhibiting Src phosphorylation at Tyr 416, with saracatinib being slightly more
potent and efficacious at inhibiting paxillin phosphorylation and AKT
phosphorylation (Fig. 4A). This was coincident with an increase in FAK
autophosphorylation upon Src inhibition. Treatment with the FAK inhibitor
blocked the autophosphorylation of FAK and decreased Src phosphorylation.
The RGD and RGD peptides did not appear to have much effect on integrin
signaling and may have increased Src and paxillin activation on 3D. Next, we
sought to determine whether these integrin signaling changes were different on
2D fibronectin coated substrate compared to the 3D CDM. We found greater
expression of fibronectin, a key component of cell-matrix adhesions and one of
the proteins possessing an RGD motif, from cancer cells grown CDM compared
to 2D and this expression was not inhibited by any pharmacological inhibitors of
integrin or focal adhesion signaling (Fig. 4B). Interestingly, while FAK
autophosphorylation was similar on 2D and 3D following treatment with the
inhibitors, the soluble RGD peptides seemed to promote a phenotype on 2D
which resembled 3D, with phosphorylation of Ser 425 of talin, a site purported to
stabilize the talin head region and implicated migration (Huang et al., 2009), and
activate Tyr 925 of FAK and downstream targets p-AKT, and p-paxillin. It may be
that while the soluble RGD peptides prevent engagement with extracellular
ligands, they also activate RGD integrin dependent signaling pathways (G. G.
Pinkse, Jiawan-Lalai, Bruijn, & de Heer, 2005; G. G. M. Pinkse et al., 2006).
Total FAK protein didn’t appear to be affected by treatment with any drugs on 2D
or 3D. These findings suggest that RGD binding integrins may be mediating
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some of the phenotypes of cancer cells observed on CDM, and that Tyr 925
phosphorylation on FAK mediated by Src may be an important effector.
To determine whether this phenotype was observed in other NSCLC cells,
we exposed the lung adenocarcinoma H2009 and A549 to varying
concentrations of saracatinib. After 24 hours exposure, we observed drastic
changes in cell attachment and morphology to H2009 cells grown on 3D CDM,
with cells detaching from the matrix and contracting into distinct cell clusters at
concentrations as low as 100 nM, while cells grown on 2D appeared less
affected (Fig. 5A). In both cell lines, we observed similar results in which
saracatinib appeared to be more potent in inhibiting Src activation on 3D than on
2D (Fig. 5B). In contrast, other pathways downstream of focal adhesion signaling
such as p44/42 MAPK (ERK1/2) signaling pathway and AKT appeared less
effected on 3D CDM compared to 2D. These findings suggest that the effect of
saracatinib on focal adhesion signaling on lung cancer cells grown on 3D CDM
may be more specific to Src inhibition than to other pathways, or that other
extracellular signals not present in 2D culture compensate for these pathways.
Given these results, we asked whether these inhibitors would be capable of
inhibiting lung cancer cell migration on a CDM. As we expected, it appeared that
collective cell migration on 3D CDM required Src activation and inhibiting FAK
kinase was sufficient to significantly stall this migration (Fig. 6A, B).
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Figure 3. Cell derived matrix alters collective cell migration morphology and
directionality.
Human adenocarcinoma cells H2030 were grown in spheroids for 4 days and transferred to
either collagen coated plastic plates (2D) or fetal lung fibroblast IMR90 cell derived extracellular
matrix (3D). A. Images of live cell time lapse microscopy depicting cancer cell migration from
spheroids at 15 minutes, 6 hours, 12 hours, and 18 hours. Scale bars are 1000 µm. B. Lines
denote migration tracks of leading cells from the spheroids on 2D or 3D substrate after 18
hours. C. Image of the leading edge of migrating cells displays cell membrane protrusions of
leading edge cells on a 2D substrate compared to a 3D substrate. Arrows denote characteristic
flat lamellopodia on the 2D substrate or extended pseudopodia on the 3D substrate.
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Figure 4. Pharmacological inhibition of integrin signaling attenuates downstream focal
adhesion pathways of lung cancer cells on CDM.
A. A549 lung adenocarcinoma cells were grown on IMR90 cell derived matrix and treated with
soluble RGD and RGDS peptides (100 µM), focal adhesion kinase inhibitor PF-573228 (1 µM),
and Src kinase inhibitors Saracatinib (10 µM) and PP2 (20 µM) for 24 hours. Western blot
analysis of extracts were probed for total focal adhesion kinase (FAK), its autophosphorylation
site (p-FAKY397), Src and its activated state (p-srcY416), phosphorylated paxillin (Y118) and
activated AKT (S473). Actin was used as a loading control. B. Western blot analysis of extracts
from A549 grown on either fibronectin coated plastic (2D) or cell derived matrix (3D) and
incubated with the indicated inhibitors for 24 hours. These extracts were probed for fibronectin,
phosphorylated talin (S425), and the Src phosphorylated site on FAK (Y925).
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Figure 5. Saracatinib more potently inhibits Src phosphorylation on 3D CDM.
H2009 and A549 lung adenocarcinoma cells were grown on either 2D or 3D cell derived matrix
and treated with varying doses of saracatinib for 24 hours. A. Representative images of H2009
cell morphology 24 hours after treatment with saracatinib. All scale bars are 100 µm. B.
Western blot analysis of extracts probed for Src, phospho-Src, phospho-AKT, FAK, phosphoFAK, p44/42, and phosphor-p44/42. Actin was used as a loading control.
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Figure 6. Inhibitors of focal adhesion signaling inhibit cancer cell migration on 3D matrix.
A549 lung adenocarcinoma cells were plated on one side of a 3D CDM, and treated with either
PF573228 (1 µM), Saracatinib (10 µM), or DMSO (V). Images were captured at the collective
cell front (0 h) and 48 hours later at the same location. B. Quantification of the average migration
distance (µm) of the cell front from the starting position. Data presented as mean ±S.E.M. from
three independent experiments. All inhibitors were determined significantly different by ANOVA
with Dunnett’s test for multiple comparison to vehicle, p < 0.001.
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Environmental hypoxia promotes cell proliferation, migration, and invasion
in a cell type specific manner
Tumor hypoxia is a critical parameter in cancer progression as hypoxia
inducible factor 1-alpha (hif-1α) mediates several parameters involved in
metastasis (Majmundar, Wong, & Simon, 2010; Masoud & Li, 2015). In an
attempt to better replicate the tumor microenvironment, we sought to use hypoxia
as a tool to test cancer cells in an environment that more closely resembles their
origin. Additionally, we intended to use this system as a tool to test hypoxic
regulation of cancer cell processes associated with metastasis, invasion and
EMT. In order to determine whether chemical or environmental hypoxia would be
more appropriate, we compared an incubator that infused gaseous nitrogen and
equipped with an oxygen sensor to treatment with a chemical inducer of hypoxia,
cobalt chloride (CoCl2). A549 cells grown under both hypoxia conditions, as well
as 2D and 3D stabilized hif-1α (Fig. 7A). However, we observed marked
activation of a number of signaling cascades under chemical treatment that were
not present under environmentally induced hypoxia (2% O 2), with induction of the
autophagy related protein LC3B-I, and activation of ERK, p38, and EGFR. Fewer
differences were observed between 2D and 3D culture, save for modest
reductions in hif-1α stabilization and AKT activation on CDM. Cancer cells grown
on CDM also had a slight activation of EGFR. While we were not directly able to
compare the oxygen concentration of media in either of the systems, we
determined that environmentally induced hypoxia would allow us to better
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observe subtle differences in signaling that may occur on the 3D CDM as well as
allow for long term cell culture.
Indeed, we found that A549 grown in physiologically relevant levels of
hypoxia (5% O2) had a slight proliferative benefit after long term culture (Fig. 7B)
and were nearly able to restore their doubling time to their traditional normoxic
2D variable (Fig. 7C). To test whether hypoxia could induce invasion, we used a
traditional scratch wound assay and overlaid this wound with the ECM compound
Matrigel. Hypoxia appeared to only slightly increase invasion into the wound, but
biochemical analysis revealed that hypoxia increased expression of the EMT
marker vimentin, and the combination of hypoxia and a Matrigel surface induced
activation of Src (Fig. 7D, E). This is expected since Src plays a pivotal role in the
phosphorylation of invadopodia components cortactin, and N-WASP, and
ultimately the recruitment of actin and MT1-MMP to invadopodia tips to promote
invasion into ECM substrates (Bailey, Airik, Krook, Pedersen, & Lawlor, 2016;
Mader et al., 2011). Next we sought to ask the question of whether this hypoxic
environment could promote migration on the CDM.
To answer this question, we created spheroids of the saracatinib sensitive
cell line H2009 and transferred them to either a collagen coated 2D surface or a
WI38 lung fibroblast CDM. As with the H2030 spheroids, we observed a
remarkably different migration pattern on 2D compared to 3D CDM, with cells on
the 2D surface migrating in a mostly radial fashion and cells on the 3D CDM
migrating from the spheroid in long, connected single cell lines (Fig. 8). However,
on both surfaces the cells appeared to migrate farther under hypoxic conditions
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compared to atmospheric oxygen culture. Interestingly, we observed different
results with the A549 and H2030 spheroids. A549 spheroids were similarly
responsive to hypoxia and spread significantly farther from the spheroid (Fig.
9A). This increase in cell spreading was coincident with a decrease in spheroid
volume in hypoxia, whereas the central spheroid remained mostly intact in
normoxia. H2030 spheroids spread equally in both atmospheric conditions (Fig.
9B). As mentioned earlier, the H2030 cell line was derived from a metastatic
lesion and possesses mesenchymal characteristics. It may be that the increased
migration observed in the other cell lines is a result of EMT. Alternatively, many
cancer cells lines have aberrant expression of hif-1α and other hypoxia response
proteins, and while this level of hypoxia (5% O2) can induce a response in some
cell lines, others may require a more stressful stimulus. As before, spheroid
collective cell migration was blunted with saracatinib treatment in normoxia and
in hypoxia. Taken together, these data suggest that environmental regulation of
hypoxia between 2-5% O2 can promote EMT, migration, and invasion
characteristics in lung adenocarcinoma cell lines in a cell line specific manner.
Further, this invasive phenotype is associated with increased Src activation and
migration on CDM matrix is effectively inhibited by blocking Src activation. Given
that focal adhesion signaling and Src activity were necessary for cell migration of
lung cancer cells on CDM, and that Src activity is upregulated during Matrigel
invasion, we asked whether interactions between CDM and cancer cells could
induce focal adhesion signaling that would also affect invasion in-vitro.
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Figure 7. Environmental and chemical induced hypoxia differentially affect cancer cell
signaling, proliferation, migration, and invasion.
A. A549 lung adenocarcinoma cells grown on either 2D or 3D CDM in atmospheric O2, 2% O2,
or treated with 1 mM CoCl2 for 24 hours. Extracts were probed for Hypoxia-inducible factor 1alpha (HIF1A), LC3, p44/42 MAPK and phospho-p44/42 MAPK, AKT and phospho-AKT, p38
and phospho-p38, EGFR and phospho-EGFR (EGFRY1068). Tubulin was used as a loading
control. B. Relative cell counts of A549 grown for 20 days in either atmospheric O2 (normoxia)
or 5% O2 (hypoxia). Data presented as mean ±S.E.M. from three independent experiments.
Statistical significance was determined by combining growth data for all timepoints of hypoxia
vs normoxia using unpaired student’s t test, p < 0.025, however individual timepoints showed
no significant differences. C. Doubling time of A549 cells following short term growth in different
environments (Statistical analysis performed by ANOVA with Dunnett’s test for multiple
comparison to 2DN, *p < 0.05, and ****p < 0.0001; data presented as mean ±S.E.M. from three
independent experiments. D. A549 cells plated at confluence and a scratch wound was created
and overlaid with Matrigel (invasion) prior to placement in normoxia or hypoxia. Quantification
of relative wound closure at 32 h, **p < 0.01; Data presented as mean ±S.E.M. E. Western blot
analysis of extracts from D, probed for vimentin, total Src, and activated Src (Y416). Actin was
used as a loading control.
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Figure 8. Physiological hypoxia promotes collective cell migration on 2D and 3D CDM.
H2009 lung adenocarcinoma cells were grown as spheroids for four days and transferred to
either a collagen coated dish or a WI38 CDM in atmospheric oxygen (N) or in a O2 controlled
hypoxic environment similar to physiological hypoxia (H). Images were captured an hour after
initial plating and at 48 hours. Images are representative of multiple spheroids. Note the distinct
migration pattern of migration on CDM where leading cells emerge and sprout in thin migrating
stalks.
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Figure 9. Hypoxia induced cell migration is cell line specific and inhibited by saracatinib.
A549 and H2030 lung adenocarcinoma cells were grown as spheroids for six days and
transferred to either a collagen coated dish or a WI38 CDM in atmospheric oxygen (N) or in a
O2 controlled hypoxic environment similar to physiological hypoxia (H) and treated with DMSO
or 5 µM saracatinib. A. Images were captured an hour after initial plating and at 120 hours
(A549) or 72 hours (2030). B. Quantification of total migrated area relative to area of spheroid.
Statistical analysis performed by ANOVA with Dunnett’s test for multiple comparison to
normoxia at each time point, *p < 0.05, and ****p < 0.0001; data presented as mean ±S.E.M.
from two independent experiments.
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Lung cancer cells on 3D CDM promote a mesenchymal mode of migration
that potentiates invasion in-vitro
In order to test whether the CDM could affect invasion of lung cancer cells,
we opted to combine our two previous assays. First, we created a CDM using the
WI38 fibroblast cell line, however we did not supplement the media with ascorbic
acid allowing for a less collagen rich matrix that was suitable for scratching
without destroying the entire matrix architecture on the plate. Next, we seeded
cancer cells at confluence in order to cover the plate and created a scratch
wound. After the scratch wound was created, we filled the wells with Matrigel
containing either vehicle or drugs involved in inhibition of focal adhesion signaling
(Fig. 10A). While previously we had observed a decreased migration of cells from
the matrix into the wound area without Matrigel, remarkably we observed rapid
wound closure of cells on the 3D CDM into the Matrigel coated wound (Fig. 10B).
Significantly increased wound closure occurred at 6, 24, and 48 hours on 3D
CDM compared to fibronectin coated 2D surface, with the greatest rates of
wound closure occurring in the first 24 hours (Fig. 10C). Interestingly, when the
cells were overlaid with Matrigel containing the FAK inhibitor PF-573228, we
observed a blunted wound closure response on 3D CDM but not on the 2D
substrate, such that the wound closure at 24 and 48 hours was not significantly
different between the two substrates. This offers evidence that focal adhesion
signaling at least in part is driving this invasive phenotype that is promoted by 3D
CDM. Finally, we observed that inhibition of Src activity with saracatinib was
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completely able to block wound closure in both 2D and 3D CDM, highlighting the
importance of Src activation in supporting cell invasion.
At this point, we had made several observations that would help us
characterize the type of migration that is occurring when lung cancer cells were
attached to a 3D CDM. Currently, two major forms of migration are thought to
occur in a 3D context, amoeboid and mesenchymal. Cancer cells undergo
plasticity that allows transition between these two states in order to facilitate
migration through soft or dense fibrous matrices. Likely, within a population, both
types of migration are occurring but exist on a spectrum of characteristics
determined by the balance of signaling which occurs in response to the surface
with which cells are interacting. Notably in our experimental context, the
morphology of the cells appears to be much more elongated and spindle shaped
similarly to fibroblasts as the cells align along the matrix. We also observed long,
cellular protrusions from the cells interacting with the ECM. Additionally, the
migration and invasion promoted by CDM interaction seem to be blunted by
blocking integrin based focal adhesion signaling. Considering these findings, we
hypothesized that the CDM was promoting a mesenchymal mode of migration
that was also facilitating the invasion into Matrigel.
At the molecular level, the dynamics of the actin cytoskeleton and the
contraction of myosin are defined characteristics in determining the modality of
migration in 3D (Paňková, Rösel, Novotný, & Brábek, 2010). During amoeboid
migration, actomyosin contractility driven by phosphorylated myosin light chain
(pMLC) downstream of RhoA and ROCK is high. Conversely, during
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mesenchymal migration, Rac1 predominates, inhibiting RhoA signaling and
promoting actin assembly and protrusion. To test whether we could recapitulate
the invasive phenotype we observed on 3D CDM using a 2D substrate, we
overlaid a scratch wound with Matrigel that contained the ROCK inhibitor GSK269962. We found that treating cells on a 2D substrate with the ROCK inhibitor
promoted similar characteristics as cells on a 3D CDM, with long cellular
projections and increased wound closure that was significantly different from
vehicle treated cells in 2D at 24 and 48 hours, but not significantly different from
vehicle treated cells on 3D CDM (Fig. 11A). Western blot analysis of lysates
produced from this experiment showed an increase in Src activation with low
levels of ROCK inhibition on 2D, but no change in FAK autoactivation (Fig. 11B).
Interestingly, further analysis of the microarray of lung cancer cells on 2D and 3D
CDM performed previously in our lab showed that expression of myosin light
chain kinase (MLCK), another kinase associated with pMLC, is downregulated on
CDM. Together, this evidence suggests that CDM interactions may promote a
mesenchymal migration phenotype that promotes invasion of Matrigel through
activation of Src.
Since we have determined the importance of focal adhesion signaling and
Src activation on increased invasion of cancer cells on CDM, we attempted to
use western blot analysis to determine some of the molecular changes that were
occurring with pharmacological inhibition of different components of this pathway
(Fig. 12A). We found that integrin αV, one of the integrin receptor heterodimer
components important in binding to fibronectin and other RGD peptides, was
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upregulated on CDM compared to 2D, that this expression was not decreased by
FAK, Src, or ROCK inhibition, but was decreased by treatment with the cyclic
RGD peptide cilengitide. This suggests that the RGD peptides we’ve used are
likely inhibiting their intended targets, however again we see that treatment of
cancer cells on a 2D substrate with cilengitide promotes a molecular response
that resembles cells grown on a CDM, with similar Src expression and activation,
paxillin phosphorylation, annexin II phosphorylation, and RhoA expression.
Similarly, EMT markers also appeared to be similar upon cilengitide treatment of
cancer cells on a 2D substrate and vehicle treatment on a 3D substrate with
decreased e-cadherin expression and increased expression of Zeb1 and
vimentin (Fig. 12B). A possible explanation for this result may be due to the
internalization of integrin αV following treatment corresponding with a switch to
another integrin heterodimer pair at the cell surface. This result was
demonstrated to occur by Jim Norman’s lab, where ovarian carcinoma cells were
treated with cilengitide or osteopontin and as a result recycled integrin α5β1 to
the cell surface to promote cell adhesion to fibronectin and mediate EGFR driven
migration into a 3D matrix (Caswell et al., 2008). This suggests the possibility
that a similar mechanism is occurring with lung cancer cells adhering to a lung
fibroblast CDM as in the original hypothesis, however further characterization of
surface integrin expression would be required for verification. On the other hand,
treatment with the focal adhesion inhibitors did not appear to affect integrin
expression or stat3 activation, however they all seemed to promote increased
Src expression and RhoA, perhaps in a compensatory response. Saracatinib
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treatment was the only agent that appeared to greatly diminish activation of
downstream Src targets paxillin and annexin II. We observed a similar inhibition
of the EMT phenotype when cells were treated with focal adhesion inhibitors,
with stabilization of e-cadherin of cells on 3D CDM, an increase of zeb1
expression, and a decrease of vimentin. Zeb1, a negative regulator of e-cadherin
expression, is promoted by stat3 activation (Xiong et al., 2012), and this pathway
appears to play a role in CDM mediated promotion of EMT (Fig. 12B).
Interestingly, blocking focal adhesion signaling restored e-cadherin expression
and diminished vimentin expression of cancer cells grown on CDM, even though
stat3 was activated and zeb1 expression increased, highlighting the importance
of cell-matrix interactions in regulating the EMT phenotype. We investigated
other known regulators of EMT, snail and slug, however we were unable to
resolve a clear picture of their expression and this may be improved by using a
nuclear extract in the future.
The EMT marker plasminogen activator inhibitor-1 (PAI-1) had
pronounced expression in cancer cells on CDM upon treatment with saracatinib.
PAI-1 regulates pericellular proteolysis by directly inhibiting the activation of
plasminogen to plasmin by binding and inactivating plasminogen activators,
urokinase and tissue type plasminogen activator. Plasmin has been
demonstrated to have a broad spectrum of activity in activating zymogens of a
multitude of MMPs in vitro including MMP-1, MMP-2, MMP-3, MMP-9, MMP-13,
and MMP-14 (Deryugina & Quigley, 2012). Given the drastically decreased
invasion upon saracatinib treatment and the importance of pericellular proteolysis
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for invasion, we decided to investigate the role pai-1 played in lung cancer cells
on the CDM. Of the three lung adenocarcinoma cell lines test, H2009, H2030,
and A549, only the A549 cell line had high levels of PAI-1 expression, although
the other cell lines had variable expression of related serine protease family
members PAI-2 and PN-1 (Fig. 13A). To understand the role of PAI-1 in cell
migration and invasion, we generated lentivirus containing CRISPR/cas9
constructs containing two different guides targeting PAI-1, a non-targeting guide,
and a pLX304 expression vector with the human SERPINE1 cDNA and stably
infected the three different cell lines. Upon expression of PAI-1 in H2009 cells,
we observed a slight but significant decrease in cell migration compared to NT,
while knock out of PAI-1 did not affect the cells (Fig. 13B).
In order to establish complete knock out of PAI-1 in A549 cells, we
isolated and characterized several clones from each of the guides (Fig. 13C) and
compared PAI-1 expression to both NT and PAI-1 overexpression clones. Loss
of PAI-1 in A549 cells significantly increased migration in clones manipulated
with either guide compared to NT, while stable expression of PAI-1 did not affect
migration in a scratch wound assay (Fig. 13D). We observed a similar result
when we assessed migration on the 3D cell derived matrix, however A549 stably
expressing PAI-1 appeared to be less migratory on ECM compared to the NT
clone (Fig. 13E). To test the ability of PAI-1 to modulate cell invasion and
proteolysis, we employed the 3D CDM Matrigel invasion assay in combination
with the pan-MMP inhibitor GM-6001, which targets MMP-1, MMP-2, MMP-3,
MMP-8, and MMP-9. Intriguingly, PAI-1 KO clones rapidly invaded into the
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wound irrespective of the MMP inhibitor, however 3D invasion was slowed with
stable expression of PAI-1 and nearly completely halted with the combination of
PAI-1 expression and treatment with the MMP inhibitor (Fig. 13F). It may be that
PAI-1 expression of the cells and GM-6001 treatment cover a broad range of
potential MMPs involved in Matrigel degradation. Alternatively, unrestricted
plasminogen activation may have effects on targets other than MMP as plasmin
directly degrades several ECM proteins. Together, these data demonstrate the
importance of pericellular proteolysis in invasion into Matrigel, and that
interrupting these processes can modulate the migratory and invasive potential of
cancer cells in different environments.
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Figure 10. CDM promotes cancer cell invasion of Matrigel which is inhibited by blocking
focal adhesion signaling.
A. Schematic representation of the scratch wound invasion assay. Cancer cells are grown on
2D or 3D CDM at confluence and a scratch wound is created. The well area is then either
overlaid with complete media containing Matrigel and treated with focal adhesion inhibitors
PF573228 (Faki 1µM), saracatinib (10µM), or vehicle (DMSO). Images of the scratch wound
area are captured at 0, 6, 24, and 48 h. B. Representative images of Matrigel wound invasion
by A549 lung adenocarcinoma cells at 0 h and 24 h on 2D surface or CDM. C. Quantification
of wound closure over a 48 h period. Each symbol represents the mean of an individual
experiment with two technical replicates. Dotted lines indicate means of multiple experiments
treated with DMSO, while solid lines indicate means of multiple experiments treated with drug.
Statistical analysis performed by ANOVA with Tukey’s test for multiple comparison at each time
point (DMSO: 2D v 3D; FAKi: 2D vehicle v 3D drug; Saracatinib: vehicle v drug) , *p < 0.05, **p
< 0.01, ***p < 0.001, and ****p < 0.0001; data presented as mean ±S.E.M. from at least two
independent experiments.
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Figure 11. Rho kinase signaling inhibition promotes cancer cell Src expression and Matrigel
invasion on a 2D substrate.
A549 lung adenocarcinoma cells were plated at confluence on either 2D (closed symbol) or 3D CDM
(open symbol), scratched, and the wound was overlaid with Matrigel containing Rho kinase inhibitor
GSK269962 (1 µM or 5 µM). A. Quantification of Matrigel wound invasion at 6, 24, and 48 h. Dashed line
indicates vehicle treatment from previous figure. Each symbol represents the mean of an individual
experiment with two technical replicates. Statistical analysis performed by ANOVA with Tukey’s test for
multiple comparison at each time point between drug and vehicle on 2DN, **p < 0.01, and ***p < 0.001;
data presented as mean ±S.E.M. from at least two independent experiments. B. Western blot analysis of
extracts from the 48 hour timepoint of the invasion assay were probed for Src, phospho-Src, phosphoAKT, FAK, and phospho-FAK. Actin and tubulin were used as loading controls.
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Figure 12. Analysis of focal adhesion pathway signaling during 3D CDM induced
invasion into Matrigel reveals roles for Src and EMT.
Lysates prepared from A549 during the Matrigel invasion assay treated with either DMSO, PF573228 1µM, Saracatinib 10 µM, GSK269962 5 µM, or Cilengitide 1 µM for 48 hours on
fibronectin coated 2D or WI38 CDM 3D were probed for members of the focal adhesion
signaling pathway and proteins associated with Src activation. A. Western blot analysis of
integrins β3 and αV, one of the heterodimer pairs known to recognize the RGD motif of
fibronectin, activated stat3, Src, activated Src, targets of Src: phosphorylated paxillin, annexin
II and phosphorylated Tyr 24 of annexin II, and the Rho family GTPase RhoA. B. Western blot
analysis of EMT markers E-cadherin, Zeb1, vimentin, slug, snail, and plasminogen activator
inhibitor 1 (pai-1). Actin was used as a loading control.
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Figure 13. PAI-1 mediates cell migration and invasion of lung adenocarcinoma cell lines
on CDM.
A. Western blot analysis of lysates from H2009, H2030, and A549 lung adenocarcinoma cell
lines grown in normoxia or physiological hypoxia (5% O2) for 24 hours were probed for PAI-1,
and related serine protease family members plasminogen activator inhibitor-2 (PAI-2) and
protease nexin-1 (PN-1). Tubulin was used as a loading control. B. H2009 cells were infected
with a lentiviral Crispr/cas9 targeting pai-1 with two different guides (g2 and g3), a non-targeting
guide (NT), and a human pai-1 expression vector. Relative wound closure of a scratch wound
(migration) in modified 2009 cells 18 hours after wounding. Each symbol represents an
independent experiment mean of two technical replicates. Statistical analysis performed by
ANOVA with Dunnett’s test for multiple comparison to NT, **p < 0.01; data presented as mean
±S.E.M. from three independent experiments. C. Western blot analysis of single clone cell lines
from A549 infected with lentiviral Crispr/cas9 and pai-1 expression plasmid probed for pai-1. D.
Relative wound closure of a scratch wound (migration) after 24 hours from selected clones with
pai-1 knock out or overexpression. E. Pai-1 knock out, NT, and overexpression A549 spheroids
were transferred to a IMR90 CDM and images were captured at 0 hours and 96 hours after
attachment. F. Pai-1 knock-out or overexpression A549 cells were plated on WI38 CDM at
confluence, scratched, and overlaid with Matrigel with either MMP inhibitor GM-6001 (25 µM)
or vehicle. Quantification of relative wound closure (invasion) at 6, 24, and 48 hours. Each
symbol indicates an individual experiment with two replicates.
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DISCUSSION
In the present study, we investigated the influence of integrin signaling in
lung cancer cells attached to a fetal lung fibroblast derived extracellular matrix on
cellular processes relevant to cancer metastasis including cell migration,
invasion, and the EMT. As our lab has previously demonstrated (Scherzer et al.,
2015), lung cancer cells on 3D CDM alter their migratory behavior on a CDM
compared to a fibronectin or collagen coated 2D surface. In the context of
collective cell migration, we found that cells maintain directional migration on a
CDM similarly to single cell migration. Surprisingly, we see that during collective
cell migration, cells on a 2D surface appear to migrate at an isotropic average
velocity that is faster than the anisotropic velocity exhibited by cells on CDM (Fig.
3). Live cell imaging revealed that as cells move collectively on 3D CDM, leader
cells extend pseudopodal projections and rapidly assemble and disassemble
cell-matrix adhesions to the ECM substrate. While precise identification of cellmatrix adhesions was beyond the scope of this study, we found that signaling
cascades downstream of integrin signaling, namely FAK and Src signaling were
required for cell migration on 3D CDM as pharmacological inhibitors of FAK and
Src slowed migration (Fig. 6).
Inhibition of Src activation appeared to be more potent on cells in the 3D
CDM compared to 2D, with diminished perturbations of AKT and ERK signaling
pathways (Fig. 5). Considering the frequent association of cell-matrix adhesions
with fibronectin, we anticipated that blocking the integrin association with the
fibronectin component of the ECM by treatment with soluble RGD peptide may
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also block the phenotypic effects observed with cell attachment to the ECM,
however upon treatment we found expression and activation of integrin signaling
pathways on 2D resembled untreated 3D CDM controls (Fig. 5). As we observed
this phenomenon with three RGD peptide based inhibitors (RGD, RGDS, and
cilengitide), this warrants further investigation of integrin “outside-in” signaling
using other tools of exogenous integrin activation, such as manganese, and
inactivation through activation blocking antibodies such as the anti-integrin β1
antibody P5D2 or the α5β1 antibody volociximab (Bhaskar et al., 2007; Ye, Kim,
& Ginsberg, 2012). As the 3D CDM matrix model is particularly suited to cell
microscopy, further evaluation of cell-matrix adhesion components and their
localization upon attachment to ECM through fluorescent confocal microscopy
would also help in delineating specific integrin interactions.
A critical component of metastasis is cell invasion of dysplastic cells
through the basement membrane layer of epithelial tissues and intravasation
through endothelial lining. To model this behavior within the tumor
microenvironment, we added the element of environmental hypoxia to our cell
culture model in order to create a microenvironment mimetic in-vitro system. A
benefit of our system is that we are able to control the atmospheric O 2 level to
between 2% and 20% that is similar to the O2 saturation of most tissues within
the body. While this is not as hypoxic as some reported levels of hypoxia in the
tumor microenvironment (Petrova et al., 2018; Salem et al., 2018), it is sufficient
to induce stabilization of HIF-1α (Fig 7). Additionally, we demonstrate that this
level of hypoxia supports and enhances cell proliferation for long term cell culture
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and potentiates invasion in A549 cells, which is correlated with induction of EMT
and activation of Src. However, hypoxia did not affect all cancer cell lines equally
as migration was increased with A549, but not with H2009 or H2030 (Fig. 9). One
possibility is the origin of the cell lines, as A549 was originally cultured from a
primary lung explant and the H2009 and H2030 were originally derived from
metastatic tissue. While they are all KRAS mutant lung adenocarcinoma cell
lines, differences may exist in their capacity to undergo and maintain an EMT
phenotype (Schliekelman et al., 2015).
Outside of the context of hypoxia, lung cancer cell interaction with 3D
CDM promoted Matrigel invasion compared to 2D culture. Treatment with a FAK
kinase inhibitor slowed this 3D promoted invasion to 2D levels, whereas Src
inhibition decreased invasion in both conditions, albeit to a greater extent on 3D
CDM. Analysis of microarray studies performed by Scherzer et al. identified that
MLCK was downregulated on two different CDMs in A549 and H358 cell lines
compared to 2D fibronectin controls. One of the targets of MLCK is the activation
of MLC and blocking this activation through pharmacological inhibition of the
Rho/Rock pathway resulted in increasing the invasive capacity of lung cancer
cells on 2D (Fig. 10). This also correlated with increased Src activation. Inhibitors
of focal adhesion signaling all stabilized e-cadherin and decreased expression of
vimentin, suggesting that this signaling pathway is also involved in the regulation
of EMT on 3D CDM (Fig. 12). However, PAI-1 expression appeared to be
markedly increased by saracatinib treatment on 3D CDM, leading us to ask about
the role of ECM remodeling and pericellular proteolysis on cancer invasion.
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Of the three cell lines tested, only A549 had appreciable PAI-1 expression
(Fig. 13). Restoring PAI-1 in the deficient cell line H2009 decreased migration,
whereas KO of PAI-1 in A549 increased migration on 2D and 3D. KO of PAI-1
also increased 3D invasion, but this was not inhibited by MMP inhibitor GM6001,
suggesting that loss of PAI-1 in lung cancer cells may increase invasion in a
mechanism that does not involve extracellular regulation of MMP but may involve
an intracellular target.
Collectively, we see that the interaction of cancer cells with the
extracellular matrix alters migration and promotes invasion through focal
adhesion signaling. Cancer cell interaction with 3D CDM promotes an elongated
cell phenotype, directional migration, EMT, invasion, and is affected by protease
regulation. Additionally, cells on 2D can transition to a 3D-like phenotype with
inhibition of Rho/ROCK and presumably through altering actomyosin related
cortical contractility. These findings suggest that interaction with a lung fibroblast
CDM promotes a mesenchymal mode of migration, that this modality of migration
is inhibited by blocking focal adhesion signaling, and also promotes local
invasion into the basement membrane. While FAK inhibition slows invasion on
3D substrates, Src inhibition blocks invasion in 2D and 3D environments, while
not affecting AKT or ERK activation in the cancer cell lines tested. Src inhibition
on 3D CDM was associated with increased expression of PAI-1, and modulation
of PAI-1 expression in cancer cells altered the migratory and invasive phenotype.
Within the tumor microenvironment, cell extrinsic elements such as the
interaction with extracellular matrix, and cell intrinsic elements such as the
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expression and regulation of proteases and PAI-1 engage in a dynamic interplay
to promote cancer cell invasion. Further understanding of essential Src
substrates or interactors in 3D environments, particularly related to invadopodia,
proteases, and their regulation may lead to improved therapeutic targets in lung
cancer metastasis.
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CHAPTER IV: TUMOR MICROENVIRONMENT MIMETIC CULTURE
AIDS ISOLATION, EXPANSION, AND POTENCY OF TUMOR
STROMAL PROGENITORS FROM PRIMARY LUNG CANCER
RESECTIONS
INTRODUCTION
The tumor microenvironment consists of a diverse milieu of transformed
and non-transformed cells that ultimately coordinate to build and maintain a
physical environment that supports tumor growth and potentiates escape and
establishment at secondary systemic sites (Quail & Joyce, 2013). These
constituents act in concert and dynamically regulate a pathological
microenvironment that modulates physical characteristics within the tumor such
as tissue stiffness, oxygen tension, and metabolite availability (Erler & Weaver,
2009; Nelson & Bissell, 2006; Vaupel, 2004). As tumors grow, these elements
promote the hallmarks of cancer such as sustaining proliferative signaling,
evading immune cell death, inducing angiogenesis, and activating invasion and
metastasis (Hanahan & Weinberg, 2011). Recent evidence implicates an
activated tumor stroma as enablers of these processes (Bremnes et al., 2011;
Pietras & Ostman, 2010).

(Portions of this chapter are published in Scientific Reports. (Saforo et al., 2019))
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The constituents of the non-tumor elements within the stroma are multiple
and varied, however the cancer associated fibroblasts (CAF) are thought to be a
major contributor to the TME stroma (Bremnes et al., 2011). CAF currently lack
specific markers but display characteristics similar to activated fibroblasts such
as expression of alpha-smooth muscle actin (αSMA) and vimentin (Amatangelo,
Bassi, Klein-Szanto, & Cukierman, 2005). They act in paracrine fashion by
producing potent proliferative cytokines that elicit mitogenic signaling within
tumor cells. Furthermore, these CAF also can directly stimulate angiogenesis via
secretion of vascular endothelial growth factor (VEGFA) and activate invasion via
production of transforming growth factor beta (TGF-β) (Navab et al., 2011; Y.
Zhang et al., 2011). CAF produce a modified extracellular matrix (ECM) which
acts as a bioactive mechanical scaffold that can influence tumor cell survival and
metastasis, as well as matrix metalloproteinases (MMP) that allow the dynamic
regulation of the ECM architecture through degradation of local matrix proteins
and activation of latent growth factors within the matrix (Cox & Erler, 2011).
Despite these critical effects on tumor homeostasis and progression, the
origin of the CAF remains elusive and may arise from a heterogeneous number
of cell types. Evidence has shown that CAF possess many characteristics of
mesenchymal stem cells, implicating these cells as a possible origin of the CAF
(Kalluri, 2016). Unfortunately, pre-clinical studies of the origin of the tumor stroma
are hampered by several challenges. Primary samples from patient tumor
resections are limited and this material is valuable for the diagnosis of the
patient. Primary cancer cell lines may be more sought after from this material,
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and successful transformation of cancer cell lines currently requires repeated
xenografts in mice during which time the tumor microenvironment is replaced by
mouse stroma (Gaggioli et al., 2007). In-vitro methods to obtain cell lines from
primary tissue resection are hindered by time to cell isolation, and these cells can
acquire changes in-vitro during the time it takes to passage them in traditional
cell culture conditions. During this time progenitor cell types may differentiate,
become quiescent, or undergo apoptosis (McKee & Chaudhry, 2017).
Various strategies have been developed to better isolate progenitor cell
types. The ECM, which is well known to modulate cell behavior through
mechanism of its mechanical stiffness, protein composition, crosslinking, and
bioactive components, has also been shown to improve culture of bone marrow
mesenchymal stem cells (MSC) (X. D. Chen et al., 2007). Culture dishes are
frequently coated with components of this extracellular matrix to promote the
adhesion and differentiation of a variety of cell types. Previously, we and others
have shown that cell-derived extracellular matrices (CDM) are replicative of the
in-vivo environment and influence cancer cell signaling to recapitulate
tumorigenic processes in-vitro (Castello-Cros, Khan, Simons, Valianou, &
Cukierman, 2009; Scherzer et al., 2015; Yamada & Cukierman, 2007). We have
shown that fetal human lung fibroblasts produce a CDM that supports lung
adenocarcinoma cells to regulate EMT processes and provide survival signaling
to promote survival in conditions of serum starvation and hypoxia (Scherzer et
al., 2015).
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Hypoxia is a critical factor in the tumor progression of solid cancers (Le et
al., 2006). Oxygen tension in physical tissues is around 2-8% and plays a role in
regulating metabolic homeostasis. Intratumoral oxygen tension can be much
lower (<0.1%) (Carreau, El Hafny-Rahbi, Matejuk, Grillon, & Kieda, 2011). In-vitro
systems that control oxygen tension have provided proliferative benefits to a
number of stromal cell types compared to traditional culture in atmospheric
normoxia (20% O2) (Mizuno et al., 2009). Culturing at physiological levels of
hypoxia has previously been reported to be critical for the cultivation and
maintenance of human stem cells (Grayson, Zhao, Bunnell, & Ma, 2007).
We hypothesized that these factors, physiological hypoxia and an in-vivolike extracellular matrix, are crucial to maintain tumor stroma, and that
incorporating these elements in a microenvironment mimetic in-vitro model would
improve survival and cultivation of primary cells from small quantities of patient
tumor resections. To test this hypothesis, we collected cells from tumor
resections of six patients with non-small cell lung carcinoma (NSCLC) and grew
them from isolation in different in-vitro environmental conditions. Utilizing a
combination of cell derived ECM and physiological hypoxia, we were able to
rapidly cultivate and massively expand populations of patient tumor associated
stromal progenitors.
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RESULTS
Microenvironment mimetic culture system characterization.
Various approaches have been used to attempt to isolate progenitor
populations from tumors and bone marrow including serum withdrawal and
specific conditioned medium, using specialized culture techniques such as
hypoxia and extracellular matrix proteins, and culturing cells using 3-dimensional
scaffolds or suspension culture. A commonality of these approaches is that each
attempt to simulate certain aspects of the physiological condition to limit the
growth of non-progenitor cell types and optimize expansion of rare or quiescent
progenitors. In order to test the hypothesis that an in-vitro culturing system
resembling the microenvironment of the human lung would facilitate the isolation
and expansion of sensitive primary patient tumor cell populations, we developed
a microenvironment mimetic culturing system that includes a fibroblast derived
extracellular matrix (ECM) and an atmosphere that maintained the oxygen
tension at a physiological level (Fig. 14A).
To characterize this system, we assessed each environmental component
individually (tissue culture plastic in atmospheric oxygen (2DN), tissue culture
plastic in physiological hypoxia (2DH), cell-derived ECM in atmospheric oxygen
(3DN), and cell derived ECM in physiological hypoxia (3DH)), and utilized two
fetal human lung fibroblast cell lines, IMR90 and WI38, and a human bone
marrow mesenchymal stem cell line (hMSC). After 72 hours of growth in each
environment, we observed a qualitative increase in WI38 cell number in single
(Portions of this chapter are published in Scientific Reports. (Saforo et al., 2019))
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conditions of 2DH or 3DN compared to 2DN, as well as an increase in cell
number in 3DH (Fig. 14B). Similarly, we observed the greatest increase in cell
number for all cell lines in the microenvironment mimetic system that combined
physiological hypoxia and cell-derived extracellular matrix (Fig. 15).
Quantification of mean cell doubling time (Fig. 14C) in the 3DH environment
showed significant decreases in IMR90 (P < 0.0099), WI38 (P < 0.0039), and
hMSC (P < 0.0001), compared to the other conditions. The single condition of
physiological hypoxia significantly decreased mean doubling time only for the
IMR90 cell line (P < 0.0387).
To assess whether the physiological hypoxia environment induced a
measurable oxygen response in the cells, we assessed stabilization of hypoxiainducible factor 1, a global regulator of oxygen homeostasis. Although western
blot analysis revealed a stabilization of hypoxia-inducible factor 1 alpha subunit
(HIF1A) in the physiological hypoxia environments (2DH and 3DH) after 72
hours, there was a considerable decrease in HIF1A stabilization in the 3DH
environment compared to the 2DH environment (Fig. 14D). Previously it was
reported that cell-derived matrices generated from stroma of various stages of
tumor progression can activate fibroblasts to undergo myofibroblastic and
desmoplastic activation (Amatangelo et al., 2005). To ensure that the matrices
from human fetal lung fibroblasts in our system were not inducing a desmoplastic
response in the cells, we assessed the expression of alpha smooth muscle actin
(A-SMA), a marker of activated myofibroblasts and desmoplastic stroma. We
found that A-SMA expression decreased in fibroblasts cultured on cell derived
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matrix and was variably affected by hypoxia, with a slight decrease in IMR90.
Additionally, we investigated regulators of cell cycle progression, and found cell
cycle inhibitors p21 Waf1/Cip1 (p21) and p27 Kip1 (p27) were also decreased in
the 3DH condition relative to the single 2DH and 3DN conditions. Taken together,
our findings suggest that despite long term culture in typical cell culture
conditions, commonly used mesenchymal fibroblast and stem cell lines cultured
in a microenvironment mimetic system experience a proliferative benefit while not
invoking a desmoplastic transformation, properties essential to the establishment
of primary cell lines from resected tumor material.
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Figure 14. Physiological hypoxia and cell derived matrix enhance proliferation of stromal
cell lines and are non-desmoplastic.
A. Schematic of cell derived matrix preparation from IMR90 fetal lung fibroblast cell line and
characteristics of microenvironment mimetic conditions. B. Phase contrast images of equal
numbers WI38 fetal lung fibroblast cells grown for 72 hours in four environmental conditions
(2D Normoxia, 2D Hypoxia, 3D Normoxia, and 3D Hypoxia). Scale bars are 100µm. C. Doubling
time of WI38, IMR90, and bone marrow mesenchymal stem cell line hMSC following short term
growth in different environments (Statistical analysis performed by ANOVA with Dunnett’s test
for multiple comparison to 2DN, *p < 0.05, **p < 0.01, and ****p < 0.0001; data presented as
mean ±S.E.M.) D. Western blot analysis of hypoxia inducible factor 1 alpha (Hif1a), alpha
smooth muscle actin (α-SMA), and cell cycle inhibitors (p21, p27) from WI38 and IMR90 after
72 hours growth in different environments.
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Figure 15. Physiological hypoxia and cell derived matrix enhance proliferation of stem
and fetal stromal cell lines.
Phase contrast images of equal numbers hMSC and IMR90 fetal lung ﬁbroblast cells grown for
72 hours in four environmental conditions (2D Normoxia, 2D Hypoxia, 3D Normoxia, and 3D
Hypoxia). Scale bars are 100 µm.
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Enhanced cell isolation and proliferation from patient tumor biopsy.
A challenge to preclinical testing of patient tumors is that resected material
is limited and precious for obtaining crucial diagnostic information. Progenitor
populations within tumors are thought to be a rare subset of this already limited
tissue. To test the hypothesis that a microenvironment mimetic cell culture
system would improve the yield of sensitive progenitor cells present within
tumors, we obtained six primary tumor resections from treatment naïve patients
with non-small cell lung carcinoma (NSCLC), including three squamous cell
carcinoma and three adenocarcinoma tumors (Table 3). In these patients,
metastasis could not be measured at the time of resection (MX) and samples
from one of the patients (1072) was later determined to have cancer present in 2
of 11 lymph nodes (N1). Specimens from the remaining tumor resections did not
have metastasis present in the lymph nodes. A portion of these resections were
prepared by enzymatic digestion to create single cell suspensions, and equal
quantities of cells were seeded onto various cell culture conditions.
The first sample tested, 927, was seeded onto the four environmental
conditions detailed above and monitored with microscopy. Seven days post
isolation, we observed cell populations of elongated and spindle cell morphology
in every environmental condition (Fig. 16A). There appeared to be an increase in
the number of attached cells in the 2DH and 3DN environments compared to the
traditional 2DN environment, however, remarkably, we observed massive
outgrowths of colonies and migrated cells in the 3DH environment. Cells
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continued to proliferate in both physiological hypoxia environments but did not
passage in the normoxia environments despite presence of extracellular matrix.
We found that all tumor samples tested in the 3DH environment showed a
marked increase in attached and proliferating cells post isolation compared to
traditional cell culture methods (Fig. 16B, D), however we did not observe any
increase in primary cell survival from adjacent normal tissue (Fig. 16C). While the
3DH environment greatly enhanced the proliferative capacity of each tumor
sample, allowing the first passage after 7 days, in most cases cells grown in
traditional methods produced a viable cell line after a moderate delay (Fig. 16D).
Similarly, when cells that were isolated in 3DH were transferred to the other
environments, we found that the cells were still viable though their proliferation
slowed (Fig. 16E). In four biological replicates, we found that the mean doubling
time significantly decreased (P < 0.009) in the 3DH environment (20.25 ± 0.7147,
n=4) compared to transfer to a traditional cell culture environment (42.82 ± 3.643,
n=4). These data indicate that a microenvironment mimetic system indeed
accelerates the establishment of a heterogeneous cell line from NSCLC
resections compared to traditional culture systems.
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Specimen
Code

Diagnosis

Staging

Histologic
Grade

Sex

Race

Age

Cell plating
density
(cells/cm2)

CDSR00927

squamous cell

T2aN0MX

III

M

white

56

4300

CDSR00955

squamous cell

T1bN0MX

II

M

white

68

CDSR00956

adenocarcinoma

T1bN0MX

II

F

black

59

T:110000;
N:12000
150000

CDSR00959

adenocarcinoma

T3N0MX

II

F

white

75

130000

CDSR00960

squamous cell

T3N0MX

III

M

white

73

57000

CDSR01072

adenocarcinoma

T2N1MX

III

F

white

75

4444

Table 3. Patient Sample Characteristics.
Bolded numbers indicate designations used for cell lines derived from tumor specimens.
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Figure 16. Physiological hypoxia and cell derived matrix synergistically enhance
proliferation of Patient Tumor Stromal-like cells.
Resected tumors were enzymatically digested with collagenase/dispase and single cell
suspensions were grown on four environmental conditions (2DN, 2DH, 3DN, 3DH). A.
Representative phase contrast images (from 5 random fields) of patient sample 927 cell growth
7 days post isolation in each condition. Scale bars are 100µm. B. Phase contrast images of
patient samples 956 and 959 obtained 7 and 6 days after isolation in 2DN and 3DH. C. Phase
contrast images of patient sample 955 tumor and adjacent normal lung cells 9 days post
isolation. D. Total cell numbers and days post isolation of 4 patient samples grown in 2D
Normoxia and 3D Hypoxia at the time of first and third passaging. E. (Upper) Doubling time of
3DH derived 927 cell line upon transfer to 4 environmental conditions. (Lower) Doubling time
of patient derived cell lines maintained in 3DH or transferred to 2DN. Statistical analysis
performed by two-tailed T-test, ***p < 0.001, n = 4; data presented as mean ± S.E.M.
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Figure 17. Population doubling level of patient sample cell lines.
A. Images of patient tumor resections prior to dissection and dissociation. Scale bars are 1 cm.
B. Phase contrast images of dissociated tumor cell growth from sample 956 7 days post
isolation showing a heterogenous cell population. Arrowheads indicate clumps of nonfibroblastic colonies. Scale bars are 100mM. C. Population doubling level of cell lines derived
from patient tumors and cultivated in 3DH.
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Primary tumor cell mesenchymal lineage characterization and
immunophenotyping.
While we observed a heterogenous population of cell morphologies in the
first week of cell isolation (Fig. 17), the spindle-shaped cells quickly outpaced the
other cell populations. We tested protein expression of epithelial and
mesenchymal cell lineages and found that while the 927 tumor resection was
highly positive for e-cadherin expression, cell lines derived from the resection
were highly vimentin positive with undetectable e-cadherin expression (Fig. 18A).
Similarly, cell lines derived from the other tumor resections did not express
detectable levels of E-cadherin or Pan-cytokeratin but were also highly vimentin
positive. Given the high proliferative capability and strict cell culture conditions
utilized in the isolation, we suspected this cell type may be a mesenchymal stem
cell. We measured surface expression of well characterized mesenchymal stem
cell markers CD90 (Thy1), CD73 (NT5E), and CD105 (Endoglin) (Fig. 18B). The
tumor derived cell lines expressed CD73 in the highest quantity, with the majority
also staining positive for CD90 as well as CD105.
Mesenchymal stem cells are also defined by their ability to adhere to
tissue culture plastic and form colonies from colony-forming unit-fibroblasts
(CFU-F). Populations of CFU-F were significantly different between patient
sample cell lines, IMR90 fetal fibroblasts, and hMSC (F (6,18) = 21.32, P <
0.0001) by one-way ANOVA. Upon multiple comparisons, all patient sample cell
lines possessed significantly greater CFU-F populations compared to IMR90 fetal
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fibroblasts (P < 0.0314), however tumor sample 959 derived in 3DH was
distinguished with significantly greater CFU-F compared to either hMSC or the
other tumor samples (P < 0.0003). There was no significant difference in tumor
samples 927, 955, or 1072 in colony forming ability compared to hMSC (Fig.
18C). Interestingly, the environment that tumor sample 959 was originally
cultivated in had a significant effect (P < 0.0003) on maintenance of colony
progenitors, where the 3DH environment maintained a greater quantity of
progenitors compared to traditional 2DN conditions. Taken together, these
findings suggest that culturing cells derived from NSCLC in a lung
microenvironment mimetic environment rapidly selects for mesenchymal stromal
cells with stem-like characteristics. Given the delay in growth in traditional
conditions and that at least one of the samples showed a difference in progenitor
characteristics depending on the environment in which it was derived, we asked
whether cells cultivated from the same tumor in different environments were
phenotypically similar.
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Figure 18. 3DH Patient derived stromal cell lines are mesenchymal and possess
mesenchymal stem cell-like characteristics.
A. Western blot analysis of tumor resection 927 and its tumor derived cell lines, fetal lung
fibroblast cell line IMR90, and lung adenocarcinoma cell line A549 (upper). Western blot
analysis of additional tumor resections and their derived cell lines probing for expression of
pan-cytokeratin (lower). B. Immunophenotyping of 3DH tumor derived cell lines with commonly
identified antigens associated with MSC (Y-axis: CD90, X-axes: CD105 (left) and CD73 (right)).
C. Quantification of Colony Forming Unit-Fibroblast (CFU-F) per 25 cells plated in 3DH tumor
derived cell lines, a matched 2DN derived cell line (2DN 959), bone-marrow derived
mesenchymal stem cell line (hMSC), and IMR90 after 16-18 days of growth. Statistical analysis
performed by ANOVA with Tukey’s test for multiple comparisons to the indicated groups, *p <
0.05, and ***p < 0.001; data presented are mean ± S.E.M.
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Environment dependent MSC multipotency markers.
Mesenchymal stem cell markers and their differentiation capacity into
various stromal cell types vary greatly depending on the sites and species from
which they are derived, and the methodology used in their isolation (Hass,
Kasper, Bohm, & Jacobs, 2011). However, human adult bone marrow
mesenchymal stem cells, similarly to pluripotent human embryonic stem cells,
were previously demonstrated to express a stage-specific embryonic antigen,
SSEA-4 (Gang, Bosnakovski, Figueiredo, Visser, & Perlingeiro, 2007). To test
whether primary cells isolated in the microenvironment mimetic environment
maintained multipotent characteristics similar to MSC, we assessed SSEA-4
expression on sample 955 via immunofluorescent labeling. We confirmed that
the majority of the cell population expressed CD90 (Fig. 19A) and observed that
most of the cells maintained SSEA-4 expression (Fig. 19B). We also tested
sample 927, which only produced viable progenitor cell lines in hypoxic
environmental conditions (2DH and 3DH). We found that only the sample that
had proliferated in the microenvironment mimetic 3DH environment maintained
strong expression of SSEA-4 (Fig. 19C). The 3DH cells were then passaged in
the other environments for 72 hours, and each of the environments maintained
SSEA-4 expression. This suggests that certain characteristics induced in the
microenvironment culture may be maintained or the rate of expression reduction
is slowed upon transfer to traditional cell culture methods.

95

In order to verify that a physiological microenvironment indeed plays a role
in the potency characteristics of derived cell lines, we assessed several markers
of stem cell potency in hMSC and the 959 cell line that had been grown in the
3DH environment. Each cell line was split to both environments and allowed to
grow for 72 hours before collection. Cells that were maintained in the 3DH
environment expressed higher amounts of the markers SOX2 and REX1 (also
known as ZFP42) compared to 2DN, but Nanog and Oct4 (also known as
POU5F1) were not significantly affected (Fig. 19A). Interestingly, when the hMSC
were transferred to the physiological condition, SOX2 and REX1 were
undetectable. Therefore, a physiological microenvironment mediates potency
characteristics of primary tumor derived stromal progenitor cells but may not be
sufficient in enhancing potency of established cell lines.
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Figure 19. 3D Physiological hypoxia cell culture selects for SSEA4 expressing tumor
derived stromal cells.
A. Phase contrast and immunofluorescence staining of IMR90 lung fibroblasts and patient
sample 955 patient tumor stromal cells for stromal marker CD90/Thy1 and nuclear stain DAPI.
B. Staining of stromal cells and human pluripotent embryonic stem cell line H1 for stage specific
embryonic antigen-4 (SSEA4). C. (left) SSEA4 expression of patient tumor stromal cell line 927
derived in either 2D or 3D hypoxia. (right) SSEA4 expression of patient tumor stromal cell line
927 3DH transferred to other environments. All scale bars are 100 µm. D. hMSC and 3DH
derived 959 were cultured in their native culture environments or transferred for 72 hours prior
to collection of RNA and protein for RT-qPCR and western blot. Relative expression levels of
pluripotency markers assessed by RT-qPCR of hMSC and 3DH 959 in different environments.
Non-detectable products were confirmed on agarose gel (lower).
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Tumor stromal cells derived in 3DH preserve tumor promoting
characteristics.
Given the possibility that we may have selected for an MSC subtype in our
microenvironment mimetic culturing system, we aimed to understand whether our
system generally activated MSC to become tumorigenic and whether tumor
derived stromal progenitor cells also produced pro-tumorigenic factors. Thus, we
assessed stromal genes related to worse prognosis and tumor progression in
both cell types. Gene expression of vascular endothelial growth factor (VEGFA)
was significantly increased (P < 0.0368) in tumor stromal cells maintained in 3DH
environment, but not greatly affected upon hMSC transfer to 3DH (Fig. 20A).
Similarly, periostin (POSTN), a secreted extracellular matrix protein that plays a
role in metastasis and is associated with a worse prognosis in a variety of
cancers (Zhu et al., 2010), had significantly higher gene expression when tumor
stromal cells were grown in 3DH (P < 0.0164) but was slightly decreased when
hMSC were transferred to 3DH. Neuron-glial 2 (NG2, also known as CPSG4), an
angiogenic pericyte protein associated with the pre-metastatic niche, and
tenascin-C, an extracellular matrix protein frequently overexpressed in lung
cancer, were not greatly affected by environment transfer in either hMSC or
tumor stromal cells. Transforming growth factor beta 1 (TGF-β) was also
increased in the 3DH environment, however when 3DH cells were transferred to
2DN they maintained slightly higher expression (Fig. 20B). Our findings suggest
that only tumor derived cells cultured in microenvironment mimetic culture alter
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their phenotype to produce a variety of pro-tumorigenic factors, and we sought to
test whether these factors might alter the phenotype of NSCLC cells themselves.
In summary, mesenchymal stromal stem-like cells derived from early, nonmetastatic tumor resections in a microenvironment mimetic environment maintain
tumor promoting characteristics in-vitro in an environmentally dependent manner.
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Figure 20. 3D Physiological hypoxia cell culture maintains expression of tumor
promoting characteristics of tumor derived stromal cells.
hMSC and 3DH derived 959 were cultured in their native culture environments or transferred
for 72 hours prior to collection of RNA and protein for RT-qPCR and western blot. A. RT-qPCR
of stromal derived tumorigenic factors of hMSC and 3DH 959 in different environments. B.
Western blot analysis of HIF1-a and TGF-b expressed in 2DN or 3DH derived 959 stroma and
transferred to different environments for 72 hours. Statistical analysis performed by ANOVA
with Sidak’s test for multiple comparisons to the indicated groups, *P < 0.05; data presented
are mean ± S.E.M.
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DISCUSSION
Previously, we have shown that lung fibroblast derived extracellular
matrices provide various benefits to lung adenocarcinoma cell lines in-vitro such
as providing resistance to apoptosis, serum withdrawal and chemically induced
hypoxia. Since the environment is a critical determinant of cell fate in NSCLC, we
expanded our in vitro system to include a physiological oxygen tension that
would resemble the microenvironment of the lung. Initially, we sought to test
each individual element of our proposed microenvironment mimetic culturing
system (Fig. 14A) and found that the individual components of hypoxia (2DH) or
cell derived ECM (3DN) enhanced mesenchymal cell growth after 72 hours (Fig.
14B). Interestingly, the combination of hypoxia and ECM appeared to have the
greatest effect on cell growth. Others have demonstrated the mitogenic benefits
of low levels of hypoxia (1-5% O2) to multiple mesenchymal cell types. Grayson
et al. showed that hMSC grown in 2% O2 improved their cell proliferation after
extended periods but did not enhance their proliferation rate (Grayson et al.,
2007). Instead, they concluded that hypoxia prolonged the proliferative state and
the cells were less affected by inhibitory signaling. Our analysis of cell doubling
time agreed with their finding as we did not observe significant differences in
doubling time for hMSC in hypoxia, and only IMR90 fetal lung fibroblasts had a
significantly hastened proliferation rate in hypoxia (Fig. 14C). However, all cell
lines tested exhibited a significant reduction in doubling time when cultured in the
combination of physiological hypoxia and ECM (3DH), suggesting that there may
be an increase in proliferation kinetics and cell cycle progression. This is
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supported by the relative decrease in cyclin-dependent kinase inhibitors p21Cip1 and p27-Kip1 in 3DH grown cells compared to 2DH (Fig 14D). This may yet
highlight another benefit of microenvironment mimetic culturing, as these factors,
as well as effects mediated by P53 and Akt, play important roles in the induction
of cell senescence, a major challenge in the culture and expansion of human
mesenchymal progenitor cells and fibroblasts (Estrada et al., 2013; Kim et al.,
2017; S. Lee et al., 2011). Indeed, we found that most cell lines tested continued
to proliferate rapidly for more than 15 passages (Fig. 17). It is possible that the
combined decrease in inhibition of cell cycle progression with the increased 3dimensional surface area allotted by the ECM act synergistically to allow
proliferation at high cell densities, resulting in a sustained proliferative response.
Given this sustained proliferative response, and the reported capability of
ECM derived from desmoplastic and tumor conditioned fibroblasts to induce
desmoplastic differentiation in stromal cells grown on those matrices
(Amatangelo et al., 2005), we also sought to determine if our system was
sufficient to promote desmoplastic differentiation of stroma. In accordance with
their finding, our fibroblast derived matrix system did not induce expression of a
desmoplastic response in normoxia or hypoxia (Fig. 14D). In addition, we found
that cells grown in 3DH had less HIF1-a stabilization compared to their 2DH
counterpart, indicating a role for the ECM in the regulation of the oxygen sensing
response and homeostasis. Taken together, these data provided evidence that
stromal cells would receive a proliferative benefit in a microenvironment mimetic
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system and that the system may not artificially accelerate the tumorigenic
potential of that stroma.
Next, we obtained small tumor resections from five treatment naïve
patients diagnosed with NSCLC (Table 3 and Fig. 17). A small portion of these
samples was dissected, enzymatically digested, and equal quantities of cells in
single cell suspensions were aliquoted into separate environmental conditions.
The first of these samples, 927, was tested in each condition (2DN, 2DH, 3DN,
3DH). After 7 days of growth, we observed cell attachment in every condition (Fig
16A), and while there was increased cell number in 2DH and 3DN, the 3DH
condition had a substantial increase in cells and numerous large colonies
covering the plate. Of the environments tested, only the hypoxia environments
were capable of cultivating cell lines. Due to the marked increase in long term
cell viability and the limited quantities of our patient samples, we chose to
consolidate our testing to traditional cell culture methods (2DN) or
microenvironment mimetic methods (3DH). Further sample isolations confirmed
our previous results, with every sample tested yielding very rapid expansion of
cells into cell lines in 3DH compared to 2DN (Fig. 16B, and D). For one biological
specimen, we were also able to acquire adjacent normal tissue, however we did
not observe the same growth benefit in 3DH (Fig. 16C). It is possible that the
number of progenitor cells present in this tissue was less than that which resides
within the tumor microenvironment and was unable to sustain a population.
Alternatively, stromal progenitor cells within the tumor microenvironment
may also undergo metabolic reprogramming to allow them to adapt more easily
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to a hypoxic cell culture system (Kalluri, 2016). Considering that we were only
able to test one specimen, it is difficult to draw conclusions and further studies
are required to determine the viability of 3DH culture in isolating primary human
tissue resident stromal progenitors. Importantly, while traditional methods
produce cell lines after a delay, 3DH isolation increases cell viability of tumor
derived stroma, and cells isolated in this environment can be transferred to
traditional cell culture (Fig. 16E), although at a slowed proliferation rate, allowing
for testing via common pre-clinical research techniques.
It should be noted that initially every sample allowed for the attachment of
a heterogenous population of cell morphologies (Fig. 17), and some of these cell
types were present and maintained their in-vivo cell polarity characteristics upon
passaging in 3DH. This suggests that our microenvironment mimetic platform
can be further manipulated to preserve other populations of cancer stem or
progenitor cells, perhaps with supplementation of specific growth factors.
Nonetheless, the majority cell type that proliferated was of mesenchymal origin
(Fig. 18A) and possessed surface expression of common markers for human
mesenchymal stem cells (Fig. 18B). Recently, there has been some discussion in
the field of the tumor associated stroma regarding the hypothesis that cancer
associated fibroblasts (CAF) may actually be quiescent mesenchymal stem cells
that become activated within the tumor (Kalluri, 2016). This is supported by
research showing that breast cancer derived CAF are remarkably similar to
hMSC in their morphology, surface marker expression, cytokine production, and
trilineage differentiation potential (Paunescu et al., 2011). The isolation and
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cultivation of CAF and hMSC is also similar and dependent upon adherence to
tissue culture plastic either from single cell suspensions or from cells that migrate
from dissected tissue fragments. When comparing the CFU efficiency of the
isolated cell lines, they were similar to hMSC (Fig. 18C), however the efficiency
of at least one cell line appeared to be significantly higher when it was isolated in
3DH compared to traditional methods. It is possible that cells isolated with
traditional methods possess MSC-like characteristics but gradually lose them and
progenitor capability over time, whereas cells isolated and maintained in 3DH
preserve those characteristics.
Multipotency is one of the defining characteristics of hMSC (Dominici et
al., 2006). Markers associated with potency are an active area of research
(Samsonraj et al., 2015), and these markers vary depending on the species, age,
and tissue of origin of the isolated cells (Chamberlain, Fox, Ashton, & Middleton,
2007; W. C. Lee et al., 2014). We found that tumor stromal progenitor cells
cultured in 3DH expressed SSEA4 (Fig. 19B, C), similarly to hMSC derived from
bone marrow. We did not observe expression of SSEA4 in 2DN derived samples,
however SSEA4 was detectable when the 3DH derived cells were transplanted
to other environmental conditions. We hypothesize that the 3DH condition selects
for and rapidly amplifies the SSEA4 positive population, whereas this population
grows at a delay in standard culture conditions before amplifying, similarly to
unsorted bone marrow samples examined by Gang et al (Gang et al., 2007).
3DH derived cells also expressed pluripotency markers Oct4, Nanog, Rex1, and
Sox2 (Fig. 19D), however only Rex1 and Sox2 appeared to be dependent upon
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the environmental condition of the cells. This corresponds with earlier studies of
bone marrow MSC and embryonic stem cells grown in hypoxia (Grayson, Zhao,
Izadpanah, Bunnell, & Ma, 2006; Westfall et al., 2008). Considering these data
and that ECM produced by bone marrow MSC plays a pivotal role in their
maintenance of stem-like characteristics, the combination of a native ECM and
hypoxia seems to isolate multipotent progenitor cells from the pulmonary tumor
microenvironment and that these cells may be MSC.
It is well known that MSCs from the bone marrow have a remarkable
capacity to home to tumors of a variety of different organs and affect their growth,
as well as their response to treatment. While it is currently not possible to
definitively identify whether the progenitor cells in the patient tumors we studied
were tissue-resident or bone marrow derived, we asked the question of whether
these tumor associated MSC had different tumor promoting effects compared to
hMSC. We found that the 3DH environment significantly increased gene
expression of angiogenesis promoting VEGF-A (Ferrara, 2004; Imoto et al.,
1998) and metastasis promoting periostin (Hong, Wei, Chen, & Shi, 2013; Zhu et
al., 2010) in a patient derived cell line, but not in hMSC (Fig. 20A), and also
increased TGF-β expression even after the cell line was transferred back to the
2DN condition (Fig. 20B).
In toto, this study demonstrates the benefits of an in-vitro culturing system
that mimics two important elements of the tumor microenvironment, physiological
oxygen tension and native extracellular matrix structure, in the isolation of
stromal progenitor cells from lung tumor biopsies. These progenitor cells express
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some commonly used markers of stem cells within our cell culture system, and
function similarly to hMSC in supporting an in vitro tumor-like environment. We
realize that many cells express these markers and more studies are needed to
fully characterize their specific identity, and given our data, especially the
potential role they may play in supporting a purported cancer stem cell
phenotype. Indeed, our findings highlight the importance of investigation using in
vitro models that reflect the in vivo condition as several tumor promoting
characteristics were revealed only in physiological hypoxia and on extracellular
matrix. Targeting factors that are producible in a physiological model may yet
lead to greater drug targeting efficacy for future anti-tumor and anti-tumor
associated stroma therapy. Additionally, this methodology may be refined to
provide further insight into progenitor cells of other tissues and assist in rapidly
expanding stem populations and preserving multipotency.
(Saforo et al., 2019)
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CHAPTER V: PATIENT DERIVED CANCER ASSOCIATED
MESENCHMYAL STROMAL CELLS DERIVED FACTORS AND
EXTRACELLULAR MATRIX PROMOTE METASTASIS
INTRODUCTION
The tumor microenvironment is composed of a diverse cellular milieu that
acts in concert to promote a pathological environment that promotes hallmarks of
tumor progression, including sustaining proliferative signaling, genome instability,
inducing angiogenesis, and activating invasion and metastasis (Hanahan &
Weinberg, 2011). Among these cellular components are transformed malignant
cells, cancer activated mesenchymal cells or fibroblasts (CAM), endothelial cells,
and inflammatory cells such as cancer associated macrophages. Importantly,
each of these cell types exist in a dynamic and occasionally labile manner as
they communicate with direct cell to cell communication or paracrine signaling.
Indeed, the cancer associated stroma is a potent source of growth factors and
microenvironment modifying enzymes that act both locally in the primary tumor
and in distal sites of the pre-metastatic niche (Hoshino et al., 2015; Li et al.,
2017; Wortzel, Dror, Kenific, & Lyden, 2019).
Recently, increased focus has delineated fibroblasts and mesenchymal
stem cells as important mediators in the tumor microenvironment as they
(Portions of this chapter are published in Scientific Reports. (Saforo et al., 2019))
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commonly secrete these growth factors and are primary producers of
extracellular matrix. When these cells interact with and are activated by cancer
cells, they in turn also modulate the activity of tumor infiltrating immune cells
including monocytes, NK cells, and macrophages, which play a role in
extracellular matrix remodeling (Kuen, Darowski, Kluge, & Majety, 2017; Yu et
al., 2017; R. Zhang et al., 2019). Matrix metalloproteinases (MMPs) and other
enzymes released by cells of the tumor microenvironment degrade the ECM, but
also activate latent growth factors and cytokines that lay dormant within the
matrix architecture (Das, Monteiro, Barai, Kumar, & Sen, 2017; Nguyen et al.,
2016; Shay, Lynch, & Fingleton, 2015). The organization of the extracellular
matrix as well as the dysplastic deposition of matrix proteins have been shown to
affect the metastatic potential of tumor cells. For example, in breast cancer,
breast density is an independent risk factor for breast cancer progression and
cancer associated modifications to extracellular matrix, including cross-linking,
stiffening, and alignment of collagen and other ECM proteins alter proliferation,
migration, and invasion of breast cancer cells (Freer, 2015; Lampi & ReinhartKing, 2018; Ondeck et al., 2019). Recently, matrikine and ECM protein profiles
have shown promise in early diagnosis of lung cancer and as predictors of
therapeutic benefit to adjuvant chemotherapy in early stage tumors (Andriani et
al., 2018; Lim, Tan, Lim, & Lim, 2017). These studies demonstrate that
alterations within the tumor microenvironment and ECM occur early during the
progression of lung cancer, however the effect of the stromal components of
early stage lung cancers are not completely understood.
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Previously we demonstrated that a microenvironment mimetic cell culture
system can amplify the isolation of a stem-like population of mesenchymal cells
from primary tumor resections. These cells differed from bone marrow derived
mesenchymal stem cells in their ability to respond to environmental factors such
as physiological hypoxia and extracellular matrix, and exposure to these
environments elicited transcription and expression of tumor promoting proteins
including transforming growth factor-beta and the matricellular protein periostin.
However, whether these cells were able to also affect the growth and invasion of
cancer cells remained an unanswered question. Do these cancer associated
cells effect the microenvironment in direct or indirect mechanisms? Are the
responses to a “normal” stromal environment and a cancer associated stromal
environment different in-vivo? What role does extracellular matrix remodeling
play in the progression of cancer?
To answer these questions, we employed physiologically relevant in-vitro
and in-vivo models including cell-derived matrices and tumor xenograft to assess
the cancer promoting characteristics of patient derived cancer associated
mesenchymal cells.
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RESULTS
Cancer associated mesenchymal cells promote proliferation, invasion, and
metastasis upon direct cancer cell interaction
Our previous findings suggest that, unlike their bone marrow derived
counterparts, tumor derived mesenchymal (CAM) cells cultured in
microenvironment mimetic culture alter their phenotype to produce a variety of
pro-tumorigenic factors (Fig. 20). We sought to test whether these factors might
alter the phenotype of NSCLC cells themselves.
To determine if direct interaction with patient derived stroma would alter
cancer cell growth, we co-cultured fluorescent nuclear labeled A549 lung
adenocarcinoma cells on different stromal monolayers. Following seven days of
growth, A549 co-cultured with patient stroma rapidly expanded (Fig. 21A) and
formed large, densely nucleated colonies compared to smaller, more linearly
arranged growth on fetal lung fibroblast monolayers. This colony forming ability
was also maintained on the MSC monolayer (Fig. 21B). Fluorescently labeled
nuclei were quantitated and one-way ANOVA revealed that different stromal
monolayers significantly affected the growth of A549 cells (F (6,9) = 36.51, P <
0.0001). We found that there was no significant difference of cell growth on either
IMR90, WI38, or hMSC monolayers, however all patient samples significantly
increased cancer cell growth compared to lung fibroblast monolayers IMR90 and
WI38 (955: P < 0.0088, P < 0.0495; 956: P < 0.0021, P < 0.0126; 959: P <
0.0001, P < 0.0001; 960: P < 0.0009, P < 0.0052). Three of the patient derived
stromal monolayers significantly increased growth compared to hMSC (956: P <
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0.0380; 959: P < 0.0001, 960: P < 0.149). Of the patient derived cell lines, 959
significantly increased cancer growth compared to the others (955: P < 0.008;
956: P < 0.0023; 960: P < 0.0053).
In order to test the ability of CAM cells to alter the invasion characteristics
of lung cancer cells, we employed a spheroid migration assay we used
previously to establish migration characteristics of cancer cells on CDM. Briefly,
we grew spheroids that contained a mixture of A549 lung adenocarcinoma cells
with either IMR90 fetal lung fibroblasts or the CAM cell line 959 (5 parts A549:1
part stroma). Next, we transferred these spheroids to a WI38 CDM and observed
migration for several days. Interestingly, we observed several cell migration
modalities that we had not previously observed when growing spheroids on CDM
with cancer cell lines alone. First, we observed that occasionally, a small cluster
of cells would separate completely from the spheroid and the cells would migrate
collectively in a small group away from tumor mass (Fig. 22A). Since we utilized
the A549 cell line that stably expressed a red fluorescent protein, we were able to
confirm that cells within this detached cluster contained a mix of cancer cells and
stromal cells (Fig. 22A). Secondly, we also observed the formation and migration
of long strands of connected cells that emerged from the central portions of the
spheroid mass (Fig. 22B). These strands were present in mixed spheroids of
both CAM and IMR90 with A549 but not in A549 spheroids alone, suggesting that
this phenomenon is a characteristic of tumor and stromal cell interactions. Again,
the strands appeared to have a mixed composition. Notably, both of these
invasion modalities are characteristic of tumor invasion in-vivo (Peter Friedl &
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Gilmour, 2009), suggesting further applications for our CDM and CAM/Cancer
spheroid model in future studies.
Since we observed a significant increase of cancer cell growth upon direct
interaction with patient tumor stromal progenitors and observed invasion
modalities characteristic of cancer cells in-vivo, we sought to determine whether
these cells isolated and grown in 3DH also displayed pro-tumorigenic ability invivo. To that end, we subcutaneously injected combinations of A549 lung
adenocarcinoma cells and stromal cell lines, separately and co-administered
(1:5), into flanks of immunocompromised NRG mice. After 30 days of growth,
tumors successfully developed in all mice bearing A549 (Fig. 23A), whereas no
tumors developed in any mice injected with only stromal cells (Fig. 23B). Oneway ANOVA comparison of mean tumor weights revealed statistically significant
differences in tumor growth with stromal co-administered tumors (F (4,35) =
3.710, P = 0.0128). While generally the addition of stroma resulted in increased
tumor growth, statistically significant increases in tumor weight compared to
solely A549 injected tumors revealed these changes may primarily be driven by
hMSC (P < 0.0450), and 955 (P < 0.0124) co-injections. Histological sections of
the subcutaneous tumors revealed that stromal populations were present and
localized toward the core of tumors in co-injections (Fig. 23C), but a prominent
stroma was not evident in the solely A549 tumors. Pulmonary histological
analysis revealed small metastatic nodules in IMR90 co-injected mice, but
prominent metastatic lesions in hMSC, 955, and 959 co-injected cohorts (Fig.
23D). Pulmonary metastasis was not detected in solely A549 injected mice. In
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summary, mesenchymal stromal stem-like cells derived from early, nonmetastatic tumor resections in a microenvironment mimetic environment maintain
tumor promoting characteristics in-vitro and promote a full metastatic program in
a normally non-metastatic adenocarcinoma cell line xenograft.
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Figure 21. Cell-cell interactions between 3DH Patient derived stromal cell lines and lung
adenocarcinoma promote cancer cell proliferation and colony formation.
Stromal cells were grown to a confluent monolayer for four days, and then equal amounts of
red nuclear labeled A549 cells were plated atop monolayers. A. (Upper) Phase contrast and
fluorescent images of A549 grown on stromal monolayers of IMR90 and patient stroma 959.
Images obtained 1 and 7 days after cancer cell seeding. (Lower) Comparison of A549 colony
formation on IMR90 or 955 monolayers on day 7. B. Comparison of A549 colony formation on
hMSC, 956, and 960 monolayers. C. Quantification of red nuclei on day 7 (mean nuclear counts
were obtained from multiple images of technical duplicate plates from 2 different experiments.)
Statistical analysis performed by ANOVA with Tukey’s test for multiple comparisons to the
indicated groups (a: vs. IMR90, P <0.01; b: vs WI38, P < 0.05; c: vs. hMSC, P < 0.05, d: vs.
959, P < 0.01); data presented are mean ± S.E.M. All scale bars are 100 µm.
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Figure 22. Co-culture of stromal cells and cancer cells promote distinct migration
patterns on CDM.
Spheroids containing a mixture of red nuclear labeled A549 lung adenocarcinoma cells and
either IMR90 or patient derived CAM (5 A549:1 Stromal cell) were grown for 4 days and then
transferred to a WI38 CDM. Images of cell migration were captured and 4 days post transfer.
A. Images of cells migrated from a spheroid containing A549 and IMR90 (left) and images of a
small detached cluster that migrated from the spheroid (right). Note that areas of the detached
cluster contain cells without red nuclei (white arrowheads). B. Comparative images of mixed
spheroids containing CAM cell line 959 or IMR90 with A549 or A549 alone. Note the distinct
multicellular invasion strands only present emanating from the mixed spheroids (right).
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Figure 23. Patient derived cancer stromal cells promote metastasis in-vivo.
955 and 959 stromal cell lines were subcutaneously injected into alone or mixed with A549
cancer cells (5:1) and subcutaneously injected into flanks of NRG mice. IMR90 and hMSC coinjections served as controls. A. Representative images of tumors excised after 30 days of
growth. B. Quantification of excised tumor weights (g) (statistical analysis performed with
ANOVA and Tukey’s test for multiple comparisons vs. A549 injection alone, *p < 0.05; data
represented as mean ± S.E.M.) C. Histology of subcutaneous xenograft tumors. Arrows indicate
areas of stromal cells; scale bars are 1 mm. D. Pulmonary histology of lungs from mice receiving
xenograft tumors (left; scale bars are 1 mm). 955/A549 and 959/A549 co-injection tumor
bearing mice with pulmonary metastasis (inset; scale bars are 500 µm). Arrows indicate
metastatic lesions.
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CAM derived extracellular matrix promotes different migration
characteristics and molecular patterns associated with invasion
Considering that mesenchymal cells are thought to be the major
producers of ECM in tissue, and that we showed CAMs alter the expression of
extracellular matrix proteins such as periostin in response to environment specific
characteristics, we asked the question of whether CDM produced by the CAM
cells would alter the behavior of cancers cells differently than a fetal lung
fibroblast derived ECM we utilized for previous studies. To accomplish this task,
we adapted our CDM protocol for use with primary CAM cells and produced ECM
coated substrates. Visually, these matrices appeared to be more complex than
IMR90 CDM, with fewer thick distinct bundles of matrix proteins and appeared
less oriented, however these characteristics remain to be accurately quantified.
We solubilized and separated the ECM produced by IMR90, as well as samples
955, 956, 959, and 960 using SDS-PAGE and stained the total protein using
Coomassie blue (Fig. 24A). We noted several distinct bands that were present in
the patient samples but were not present in the IMR90 CDM, as well as an
altered relative abundance of high molecular weight proteins. A proteomic
analysis of the precise identification of these proteins, their abundance,
localization, and gross linearity would likely inform future studies, however from
our current data we can determine that each of these samples are different. In
order to determine whether these changes in CDM could alter the migration of
cancer cells, we transferred A549 and H2030 spheroids onto the different ECM
and observed their migration (Fig. 24B, C). Surprisingly, with both cell lines we
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observed decreased migration on the patient derived CDM compared to the
IMR90 CDM. Again, we observed a directionality of migration on the patient
derived CDM (Fig. 24C) and what appeared to be distinct “leader” and “follower”
cell phenotypes. Qualitatively, it appeared as though the number of cells
transitioning from collective to single cell migration was increased on the CAM
CDM, and that the velocity of cells that separated from the mass appeared
greater than that of cells connected to the spheroid, however we were unable to
find a method of analyzing these parameters in an unbiased manner with
potentially thousands of cells migrating independently.
In an attempt to assess single cell migration behavior, we plated the
nuclear labeled A549 cells onto the CAM CDM, IMR90 CDM, or collagen coated
plastic (2D) and used time lapse microscopy to observe the cells in real time.
Again, note that cancer cells grown on IMR90 CDM possess morphologies that
resemble mesenchymal migration, with clearly polarized cell bodies that align
themselves along the matrix and cellular projections that navigate along the
matrix strands in an ordered fashion (Fig. 25A). Immediately, we were able to
recognize distinct difference in cancer cells grown on the CAM CDM, where cells
made multiple and multipronged pseudopodia adhesions to the matrix that
appeared to be maintained for much of the observed period. Concurrently, many
of these cells were not motile in this condition and the fluorescent nuclei
appeared to be squeezed into oblong shapes as the cells sensed and adjusted to
the extracellular matrix. This altered cell adhesion also appeared to affect cell
division, as some cells on the CAM CDM would appear to enter prolonged cell
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division and then either complete cytokinesis to emerge with multinucleated cells
(Fig. 25B) or exit mitosis without completing cytokinesis and becoming
multinucleated (Fig. 25C). Recently, increasing emphasis is placed on nuclear
membrane integrity in cancer as tension and stress induced by extracellular
forces promote nuclear membrane instability and deformability, resulting in
genomic instability, MMP mediated invasion and associated with aggressive
malignant disease (Denais et al., 2016; Dornier & Norman, 2018; Infante et al.,
2018). Considering that cell-matrix adhesions on all CAM CDMs appeared to be
stable compared to the IMR90 matrix, we hypothesized that cancer cells on
these matrices may also have sustained focal adhesion signaling. Indeed,
western blot analysis of FAK activation showed increased phosphorylation at Tyr
397, Tyr 925, and Tyr 576, as well as associated phosphorylation of paxillin and
elevated expression of integrin linked kinase of cancer cells grown on the patient
CAM CDM compared to IMR90 CDM (Fig. 26). Additionally, cancer cells
increased activation of Src on all three patient CAM CDM, although showed little
change in AKT from 2D conditions. Strikingly, interaction with the CAM CDM also
greatly decreased PAI-1 expression in the cancer cells. Collectively, we have
previously shown that this molecular pattern in A549 cells is associated with
increased invasion into Matrigel, and here we can see that such a pattern can be
promoted solely by interaction with extracellular matrix derived from cells isolated
from patient tumors.
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Figure 24. Patient derived CAM CDM has distinct protein composition and alters cancer
cell migration.
IMR90 or patient CAM cells were grown at confluence for 8 days with media supplemented with
ascorbic acid every other day to produce CDM. Matrices were denuded of cells and then
solubilized and separated using SDS-PAGE. A. Total proteins were visualized with Coomassie
blue to show distinct expression patterns. A549 and H2030 lung adenocarcinoma spheroids
were grown for six days and transferred to either IMR90 CDM, patient CAM CDM, or 2D
collagen. B. A549 spheroids on ECM exhibited less migration on patient CAM CDM compared
to IMR90 CDM after 120 hours. C. H2030 spheroids migrated over less total area on patient
CAM CDM than IMR90 CDM, with cells frequently transitioning to single cell motility on CAM
CDM.
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Figure 25. Patient CAM CDM stabilizes cell-matrix adhesions and alters cell division in
cancer cells.
Red nuclear labeled A549 were grown on either IMR90 CDM or patient derived CAM CDM and
cell behavior was observed via time-lapse microscopy with images captured every 15 minutes
for 24 hours. A. Cell morphology of A549 cells on either IMR90 CDM, with clear cell polarity
and mesenchymal appearance, and patient derived CAM 959 CDM, with cells exhibiting
multiple projections to the matrix and constricted nuclei. B. A cluster of A549 cells on CAM 956
CDM demonstrates aberrant cell cycle progression with a binucleated cell (left; white arrow)
dividing into a cell with three nuclei (right; white arrows). C. A binucleated A549 cell attempts
and aborts cell division, resulting in a cell with four nuclei.
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Figure 26. Patient CAM CDM promotes activation of focal adhesion signaling pathways
and an invasive molecular phenotype in cancer cells.
A549 cells were grown on either a 2D surface, IMR90 CDM, or patient CAM CDMS (956, 959,
and 960) CDM and lysates were collected and probed for proteins involved in focal adhesion
signaling and 3D invasion, including focal adhesion kinase (FAK), and its phosphorylated sites
Tyr 397, Tyr 925, and Tyr 576, integrin linked kinase (ILK), Src, activated Src (Tyr 416), AKT,
activated AKT (Ser 473), and plasminogen activator inhibitor-1. Note that the three patient
derived CDM similarly increase FAK and SRC activation, as well as down regulate PAI-1
expression, characteristics associated with invasion in cancer cells.
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Revisiting the PAI-1 paradox using an in-vitro model of the tumor
microenvironment
For decades, the plasminogen-plasmin activation system has been
intensely researched due to many elements of the system regulating tissue
processes aside from fibrinolysis and the coagulation cascade, including cell
senescence, proliferation, angiogenesis, and migration. Indeed, intracellular
signaling downstream of the urokinase plasminogen activator receptor (uPAR)
has been found to be related to activation of many integrin linked proteins found
to be associated with tumor invasion used in this study including FAK, Src,
paxillin, AKT, and EGFR (Mauro et al., 2017; H. W. Smith & Marshall, 2010).
However, in a well-known paradox, PAI-1, the main inhibitor of uPAR mediated
plasminogen activation is also associated with poor prognosis in several solid
cancers, including breast and lung (Foekens et al., 1994; Lin et al., 2017; Look et
al., 2002). Further, PAI-1 is expressed by adult and fetal mesenchymal stromal
cells in the human lung (Rolandsson Enes et al., 2016). In order to understand
the PAI-1 paradox in the context of our co-culture system of cancer cells and
patient derived CAM cells, we first set out to verify that the stromal cells were
also expressing PAI-1.
We found that while lysates prepared from resected tumor material from
patients initially had little or low PAI-1 expression, the stromal cell lines and the
IMR90 fetal lung fibroblast cell line had relatively high expression (Fig. 27A).
Additionally, to understand the contribution of cancer and inflammation to PAI-1
expression in the lung, we used a repeated cisplatin dosing model in FVB mice
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bearing lung tumors to recapitulate chemotherapeutic treatment of patients in the
clinic (Sharp et al., 2016). Interestingly, while tumor bearing mice did not have
different differences in PAI-1 expression in the lung, animals treated with cisplatin
had a moderate increase in PAI-1 expression and the cohort of tumor bearing
mice that received chemotherapy had the highest measured expression (Fig.
27B). This lends further evidence that the stroma, and particularly the tumor
reactive stroma, is a major contributor of PAI-1 in the tumor microenvironment.
Next, we sought to understand the consequence of loss of PAI-1
expression in cancer cells during co-culture of PAI-1 expressing stromal cells.
Interestingly, we found that in the early days of co-culture, cancer cells
segregated into small cell clusters surrounded by thick layers of stromal cells in
an organized pattern, regardless of PAI-1 KO or overexpression in the A549 cells
(Fig. 27C). While this delineation was maintained after a week of co-culture in
PAI-1 expressing A549, PAI-1 KO A549 proceeded to invade and grow into the
stromal sections of the culture plate. These data indicate that loss of PAI-1 in
cancer cells results in a phenotype that cannot be rescued by extracellular PAI-1
secretion. Next, we assessed whether migration of the PAI-1 manipulated cells
would be affected by the CAM CDM, as previously we observed a
downregulation of PAI-1 in cells plated on the patient derived substrates.
Previously, we found that overexpression of PAI-1 in A549 resulted in less
spheroid migration compared to NT or PAI-1 KO on an IMR90 matrix (Fig. 13E),
however on the CAM derived matrix we observed little difference in migration
between the NT and PAI-1 Overexpression spheroids (Fig. 28A). As before,
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saracatinib completely blocked migration and loss of PAI-1 expression in A549
greatly increased spheroid migration. To model the effect of PAI-1 secretion from
the stromal cells, we also added recombinant PAI-1 to the media of migrating
spheroids. Interestingly, the addition of PAI-1 had the effect of enhancing cell
migration in all the cell lines tested, with the greatest migration observed in the
A549 PAI-1 KO cells treated with recombinant PAI-1 (Fig. 28 B, C). According to
our previous findings, this condition of high extracellular stromal PAI-1 and low
intracellular cancer PAI-1 expression would most accurately resemble the
conditions of cancer cells responding to a tumor reactive extracellular matrix
within the tumor microenvironment. Further consideration of these parameters in
a microenvironment mimetic system may add to our understanding of the PAI-1
paradox, particularly in cell migration and cell-matrix interactions.
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Figure 27. PAI-1 is expressed by cells of the tumor stroma, and loss of PAI-1 in cancer
cells promotes invasion into tumor stroma.
To assess the expression of PAI-1 in stromal cells, we used the CRISPR/cas9 lentivirus
containing guides for PAI-1 to stably modify the fetal lung fibroblast cell line IMR90, and probed
for PAI-1 via western blot analysis (left). In addition, we compared the total PAI-1 expression in
lysates derived from the primary tumor resections from patients and compared them to the CAM
cell lines derived from those tumors (right). Gapdh was used as a loading control. B. PAI-1
mRNA expression was measured in the lung of FVB mice 8-weeks of age (Y) or middle-age (6months old) (M) with or without non-small cell lung carcinoma and treated with 4-doses of
vehicle or cisplatin, 1-wk apart and sacrificed 72 hr after the last injection, demonstrating
increased PAI-1 expression in a physiologically relevant cancer model in-vivo. C. Images of coculture of CRISPR KO or overexpressed PAI-1 A549 cells and WT IMR90 fibroblasts (10:1) 2
and 7 days post culture. Note delineated tumor margins in NT and PAI-1 expressing A549 while
PAI-1 KO A549 invade into the stromal margin.
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Figure 28. Exogenous PAI-1 promotes spheroid migration on CAM CDM.
CRISPR/cas9 PAI-1 KO, NT, and PAI-1 overexpressing A549 were grown in spheroids and
then transferred onto CDM produced by either patient CAM cell lines 959 or 960. A.
Quantification of cell migration from PAI-1 manipulated spheroids treated with either vehicle or
saracatinib (5 µM) 72 hours after transfer to CDM. To assess the role of non-tumor derived PAI1 on cell migration, NT, PAI-1 KO (B) and PAI-1 overexpressing spheroids were transferred to
a WI38 CDM and treated with complete media, saracatinib (5 µM), or recombinant human PAI1 (1.33 µg/mL) and images were captured at 72 hours. C. Quantification of spheroid migration.
Each symbol represents one spheroid. Data presented are means ± SEM from one experiment.
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DISCUSSION
In the present study, we assessed the contributions of tumor derived
stroma in affecting the metastatic characteristics of lung adenocarcinoma cells.
To accomplish this goal, we used cell lines that were derived from tumor
resections from patients with treatment naïve early stage lung cancer (Table 3).
Previously we established that several genes associated with tumor progression
and stemness were upregulated in these cells in an environment dependent
manner, where a microenvironment mimetic culture system stimulated many of
these factors (Fig. 20). We employed direct co-culture of A549 cells with primary
tumor stroma or fetal lung fibroblast cell lines to test the effects of the tumor
derived cells on cell proliferation. Patient stroma also significantly increased
A549 lung adenocarcinoma cell growth in this direct co-culture model in-vitro
compared to hMSC and fetal lung fibroblasts (Fig. 21C). Interestingly, A549
clustered into dense nests of cells when cultured on hMSC or patient stromal
monolayers, but not on the fibroblast monolayers (Fig. 21A, B). These cell nests,
as well as nests observed in early culture of NSCLC derived cell lines (Fig. 17),
resembled sphere forming cancer stem cells (CSC) induced in a CSC/CAF coculture system (W. J. Chen et al., 2014). It is possible that the microenvironment
mimetic culture method also plays a role in establishment or maintenance of
CSC populations, especially in the context of additional paracrine signaling with
tumor stroma. Since CAF have been demonstrated to produce exosomes that
regulate tumorigenic properties of other cancers, it would be interesting to know
whether direct interaction of cancer cells with tumor stroma is required to incite
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these properties or treatment of conditioned media from the stroma is sufficient to
alter cell proliferation and stem-like characteristics (Richards et al., 2017).
Remarkably, while co-culture of cancer cells and stromal cells didn’t
drastically alter spheroid morphology, transfer of these spheroids to extracellular
matrix revealed some intriguing differences in collective cell migration. While we
had observed cell streaming from spheroids in a collective manner previously,
upon co-culture we witnessed collective migration phenotypes normally observed
in-vivo including the migration of cells in small, separate clusters or in long, thin
strands that remained connected to the spheroid mass (Fig. 22). Fluorescent
imaging showed that these multicellular structures contained a majority of cancer
cells with a small quantity of stromal cells dispersed in between. Future in-vitro
studies may focus on elucidating the molecular mechanisms underlying this
association of cells as these structures are proposed to play a role in the survival
of circulating tumor cells to promote metastasis (Clark & Vignjevic, 2015;
Fabisiewicz & Grzybowska, 2017; Giuliano et al., 2018).
As we established that stromal cells potentiate tumor migration patterns
in-vitro that are normally observed in-vivo, we asked the question of whether
these tumor-stromal cell interactions would drive tumor growth and metastasis invivo. To understand these interactions in vivo, xenograft studies demonstrated
that subcutaneous co-injection of A549 with stroma significantly increased tumor
size compared to A549 alone (Fig. 23A, B), and that this stroma remained
present and localized toward the core of the tumor (Fig. 23C). Further, both
cohorts of mice bearing patient stromal tumors developed metastasis to the lung,
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similarly to hMSC injected mice while not in A549 alone (Fig. 23D). This suggests
that patient stroma can promote a normally non-metastatic cancer cell line to
undergo the full metastatic process.
Whether this effect is due to the increased expression of stromal TGF-β,
VEGF-A, periostin, or another stromal derived factor remains to be elucidated.
However, we did find that we were able to use our CDM model to create
extracellular matrices from the patient derived stromal cell lines. Interaction with
the extracellular matrix alone altered the normal 3D migratory behavior and
promoted an invasive phenotype in the cancer cells. Specifically, we observed
sustained cell-matrix adhesions and focal adhesion signaling (Fig. 25). This led
to reduced migration and errors in cell proliferation as cells divided and became
multinucleated. Considering that the ECM produced by fetal lung fibroblasts and
primary tumor stromal cells is different (Fig. 26), an understanding of the specific
ECM proteins interacting with cancer cells, as well as other physical
characteristics of the CAM CDM are warranted. Targeting these adhesion
mechanisms or the downstream signaling cascades following their interaction
may provide therapeutic benefits to early stage cancer patients to help limit
progression. Additionally, we have not yet tested the ability of these CAM CDM to
promote tumorigenic characteristics in non-transformed lung epithelial cells. Are
these invasive responses due to sustained signaling downstream of oncogenes
such as KRAS or are they independent of driver mutations and a general feature
of cell interaction with a cancer associated ECM? Do cancer cells also contribute
to the remodeling of the ECM produced by a tumor reactive stroma?

136

A hint toward the latter question was revealed when we found that PAI-1 is
downregulated in cancer cells that interact with a CAM CDM (Fig. 26). PAI-1
prevents pericellular proteolysis and ECM degradation mainly through inhibiting
the action of plasmin, and downregulation of PAI-1 may lead to an imbalance of
the plasminogen-plasmin system within the tumor and may promote local
remodeling. However, we also see that stromal cells within the lung tumor
produce PAI-1 in the tumor microenvironment, and when we knocked out PAI-1
in the tumor cells, we still observed an invasive phenotype into the stroma (Fig.
27). Addition of recombinant PAI-1 also promoted migration on ECM, suggesting
that extracellular PAI-1 may enhance cancer cell motility regardless of the
expression of the cancer cells (Fig. 28). The cell intrinsic and extrinsic effects of
PAI-1 may potentiate each other to promote an invasive phenotype. Takashi
Yahata et al. found that intracellular, but not extracellular, PAI-1 inhibited the
cleavage and activation of the pro-peptide of MT1-MMP by the proprotein
convertase furin in murine hematopoietic stem cells (Yahata et al., 2017). A
similar mechanism may be occurring in cancer cells. Further molecular
characterization of invasion associated genes, as well as understanding of posttranscriptional regulation of PAI-1 on cancer CDM, would provide valuable insight
to the PAI-1 paradox in lung cancer. Development of therapeutics to inhibit the
extracellular effects of PAI-1 may therefore be worthwhile to investigate.
Alternatively, restoring PAI-1 expression in cancer cells may also prevent the
invasive phenotype observed. To test this hypothesis would require a transient
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CRISPR/Cas9 editing system that would enable stable genetic knockout and
plasmid mediated exogenous expression.
This work further enables the clinically relevant study of patient specific
tumor features that are sufficient to promote tumor growth and metastasis.
Interactions with primary stromal cells from lung tumors, even from patients that
clinically do not present with metastasis, are capable of promoting metastasis in
a xenograft model. We see that the extracellular matrix produced by these cells
is different, and that this matrix can modulate cell behavior and protein
expression. On the other hand, an equally important question that remains to be
addressed is what factor in the tumor microenvironment of these early stage
patients is sufficient to impede the tumor promoting characteristics we see from
the cancer associated ECM? How are these factors lost in the course of cancer
progression, and could their restoration prevent metastatic dissemination and
disease in late stage patients? Targeting factors that are producible in a
physiological model may yet lead to greater drug targeting efficacy for future antitumor and anti-tumor associated stroma therapy.
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CHAPTER VI: SUMMARY AND CONCLUSIONS

The overall goal of this dissertation was to determine how ECM interactions with
lung adenocarcinoma cells can promote hallmarks of cancer metastasis in a
physiologically relevant in vitro model that included a lung fibroblast cell-derived
extracellular matrix (CDM) and physiological levels of hypoxia that approximate
the amount of oxygen present in the lung microenvironment. This work
continued from a study previously performed by Scherzer et al. that
demonstrated that lung adenocarcinoma cells cultured on a CDM altered their
morphology, proliferation, migration, and survival to serum withdrawal (Scherzer
et al., 2015). Additionally, he performed a microarray study which compared the
gene expression of two lung adenocarcinoma cell lines, A549 and H358, on two
different CDM and a 2D fibronectin coated surface. These data allowed for us to
answer more specific questions regarding the regulation of molecular interactions
that occur when cells encounter extracellular matrix.
We were able to identify integrin signaling as a key component of
extracellular matrix interaction in lung adenocarcinoma cells in promoting
migration and EMT. Activation of Src family kinases was required for 3D enabled
migration and invasion. Interaction with 3D CDM in a process that appeared to
be downstream of integrin binding to fibronectin through an RGD motif switched
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the modality of migration and potentiated invasion into Matrigel. This process
was also associated with protease activity under the regulation of PAI-1.
Inhibition of Rho/ROCK inhibits the activation of MLC and promoted similar
invasion of 2D cells as cells on 3D CDM. Together, these data suggest that lung
cancer cells on a 3D CDM utilize a mesenchymal mode of migration to facilitate
invasion (Fig. 29).
We also utilized a microenvironment mimetic culture system that included
the combination of 3D CDM and physiological hypoxia to greatly amplify the
isolation and proliferation of cells from enzymatically digested primary human
tumor resections. We extensively characterized the cell populations that derived
under this condition as a cancer associated mesenchymal stem-like cell, and we
found that these cells produced tumorigenic factors in an environment dependent
manner unlike their bone marrow derived counterparts. This environment was
also critical in maintenance of stem potency gene expression and may be used in
the future to isolate rare progenitor cell populations from other tissues.
Finally, we assessed the ability of these primary tumor resected stromal
cells to affect lung adenocarcinoma growth and metastasis. These cells
stimulated cancer cell proliferation in-vitro and could promote a full metastatic
cascade in a xenograft mouse model using a normally non-metastatic human
lung adenocarcinoma cell line. We established 3D CDM from these cells and
identified that their ECM differs from fetal lung fibroblast CDM in composition and
in function of altering the phenotype of cancer cells. Lung adenocarcinoma cells
on patient stromal CDM stabilized focal adhesions, displayed slowed migration
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and nuclear instability, and demonstrated a highly invasive molecular profile with
increased Src activation and decreased intracellular PAI-1. Interestingly, these
stromal cells also produce and secrete PAI-1 into the extracellular environment.
We found that migration of cancer cells genetically deficient in PAI-1 was
increased on 3D CDM following addition of recombinant PAI-1 protein to the
media. These findings suggest a novel possible explanation for the PAI-1
paradox, in which cancer associated stroma produces extracellular matrix that
results in the downregulation of PAI-1 within the cancer cell, and supports cancer
cell migration by secreting PAI-1 into the tumor microenvironment.
In conclusion, we identified molecular mechanisms that promote cancer
metastasis in-vitro and in-vivo through extracellular matrix interactions in the
tumor microenvironment. Further understanding of these interactions and specific
microenvironment related targets may lead to improved therapeutics for lung
cancer patients suffering from or at risk of developing metastatic disease.
Strengths
We utilized a physiologically relevant in-vitro model of lung cancer in order to
explore molecular targets with possible in-vivo significance. This
microenvironment mimetic model provided us with new information about the
modality of migration and invasion in lung cancer cells that is triggered upon
interaction with a physiological extracellular matrix substrate. In a direct test of
this system, we were able to improve the isolation and proliferation of primary
cells derived from patients with early stage lung cancer and demonstrated that
these cells promote metastasis in an in-vivo model. The techniques utilized in
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this dissertation can be widely applied to cancers of other tissues and are highly
reproducible.
Limitations
One of the benefits of the 3D CDM system is that it is highly amenable to light
and fluorescent microscopy. Data produced from this dissertation suggested that
collectively migrating cells are highly diverse and exhibit a “leader and follower”
phenotype. However, a majority of the assays used sampled the entire
population of cells rather than those at the leading edge of cell migration that
may be biologically significant. Further exploration of the localization and
phosphorylation of important proteins in integrin signaling and their interactors
utilizing techniques such as Fluorescence resonance energy transfer (FRET)
microscopy and fluorescence recovery after photobleaching (FRAP) may provide
illuminating information in the search for precise molecular targets. Additionally,
all lung adenocarcinoma cell lines used in this study harbored KRAS mutations,
which only accounts for around 30% of lung adenocarcinoma. Study of cell lines
possessing different driver mutations may provide information on whether the
increased invasion observed with contact with 3D CDM is a RAS specific effect
or general for NSCLC.
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Figure 29. Model of cell-matrix interactions and signaling pathways that promote
migration and invasion on CDM.
Cancer cells grown on 2D substrates differ in their ability to promote migration and invasion
compared to cells interacting with 3D CDM. A. Focal adhesion signaling downstream of RGD
binding integrin through FAK and Src family kinases is required for 3D cell migration and EMT.
Inhibition (i) of Src results in stabilization of E-cadherin, upregulation of protease inhibitors, and
decreased invasion, but ERK and AKT activation may be supported by alternative mechanisms.
B. Lung cancer cells on 3D CDM downregulate MLCK. Inhibition of RhoA/ROCK signaling
phenocopies the invasive phenotype to cancer cells grown on 2D. This suggests contact with
3D CDM may alter the balance of cytoskeletal remodeling to favor actin polymerization over
myosin contractility. Collectively these characteristics support the definition of 3D mesenchymal
migration.
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Mentor: Leah Siskind, Ph.D.
•

Significance: This research was focused on studying the
effects of currently employed chemotherapy. The major
dose limiting toxicity for cisplatin, a common
chemotherapy used in a variety of cancers, is kidney
injury. We investigated the potential of targeting the
metabolism of sphingolipids to protect mouse kidney cells
from chemotherapeutic-induced injury. This project
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metabolism and isolation, molecular biology techniques
like overexpression and knockdown of genes using
lentiviral delivery of shRNA, qPCR, and multiple
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based mitotic inhibitors. My research focused on
targeting a protein complex, the Anaphase Promoting
Complex/Cyclosome (APC/C), to disrupt the cell cycle
and cause death in ovarian cancer cells while sparing
normal tissue. Previously, researchers in Dr. States’ lab
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Induce Mitotic Arrest in Ovarian Cancer. 2012 Research Louisville,
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• This poster, presented by the candidate, won 1st place in the
Undergraduate student category.
• This poster was also presented at the James Graham Brown
Cancer Center Annual Retreat in Louisville, KY, and at the Postersat-the-Capitol meeting in Frankfort, KY.
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Travel Award and the Minority Undergraduate Education Program
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Physician Scientist Association Meeting at Ohio State University in
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for the treatment of acute kidney injury. 2015 Southeastern Medical
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Siskind. In-vitro 3-Dimensional modeling of the tumor
microenvironment in non-small cell lung carcinoma. 2015 Research
Louisville, Louisville, KY.
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Underrepresented Trainee Travel Award to the American Physician
Scientists Association Annual Meeting in Chicago, IL.

5.
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Siskind. In Vitro 3-Dimensional Modeling of Tumor Microenvironment
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This abstract was selected for a travel award to the 2017 Gordon
Research Conference and Seminar.
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